id	sid	tid	token	lemma	pos
iajs-314	1	1	microsoft	microsoft	PROPN
iajs-314	1	2	word	word	NOUN
iajs-314	1	3	15	15	NUM
iajs-314	1	4	493	493	NUM
iajs-314	1	5	|	|	ADV
iajs-314	1	6	chemistry	chemistry	NOUN
iajs-314	1	7	2014	2014	NUM
iajs-314	1	8	)	)	PUNCT
iajs-314	1	9	عام	عام	ADP
iajs-314	1	10	3(العدد	3(العدد	NUM
iajs-314	1	11	27المجلد	27المجلد	NUM
iajs-314	1	12	مجلة	مجلة	VERB
iajs-314	1	13	إبن	إبن	NOUN
iajs-314	1	14	الھيثم	الھيثم	NOUN
iajs-314	1	15	للعلوم	للعلوم	NOUN
iajs-314	1	16	الصرفة	الصرفة	NOUN
iajs-314	2	1	و	و	PRON
iajs-314	2	2	التطبيقية	التطبيقية	ADJ
iajs-314	2	3	ibn	ibn	PROPN
iajs-314	2	4	al	al	PROPN
iajs-314	2	5	-	-	PUNCT
iajs-314	2	6	haitham	haitham	PROPN
iajs-314	2	7	jour	jour	X
iajs-314	2	8	.	.	PROPN
iajs-314	2	9	for	for	ADP
iajs-314	2	10	pure	pure	ADJ
iajs-314	2	11	&	&	CCONJ
iajs-314	2	12	appl	appl	PROPN
iajs-314	2	13	.	.	PUNCT
iajs-314	3	1	sci	sci	PROPN
iajs-314	3	2	.	.	PUNCT
iajs-314	3	3	vol	vol	NOUN
iajs-314	3	4	.	.	PROPN
iajs-314	4	1	27	27	NUM
iajs-314	4	2	(	(	PUNCT
iajs-314	4	3	3	3	NUM
iajs-314	4	4	)	)	PUNCT
iajs-314	4	5	2014	2014	NUM
iajs-314	4	6	evaluation	evaluation	NOUN
iajs-314	4	7	of	of	ADP
iajs-314	4	8	il-35	il-35	ADP
iajs-314	4	9	and	and	CCONJ
iajs-314	4	10	hs	hs	PROPN
iajs-314	4	11	-	-	PROPN
iajs-314	4	12	crp	crp	PROPN
iajs-314	4	13	in	in	ADP
iajs-314	4	14	iraqi	iraqi	ADJ
iajs-314	4	15	patients	patient	NOUN
iajs-314	4	16	with	with	ADP
iajs-314	4	17	cardiovascular	cardiovascular	ADJ
iajs-314	4	18	diseases	disease	NOUN
iajs-314	4	19	warka'a	warka'a	PRON
iajs-314	4	20	t.	t.	PROPN
iajs-314	4	21	al	al	PROPN
iajs-314	4	22	-	-	PUNCT
iajs-314	4	23	sa'adi	sa'adi	PROPN
iajs-314	4	24	dept	dept	NOUN
iajs-314	4	25	.	.	PROPN
iajs-314	4	26	of	of	ADP
iajs-314	4	27	chemistry	chemistry	NOUN
iajs-314	4	28	/	/	SYM
iajs-314	4	29	college	college	NOUN
iajs-314	4	30	of	of	ADP
iajs-314	4	31	education	education	NOUN
iajs-314	4	32	for	for	ADP
iajs-314	4	33	pure	pure	ADJ
iajs-314	4	34	science	science	NOUN
iajs-314	4	35	(	(	PUNCT
iajs-314	4	36	ibn	ibn	PROPN
iajs-314	4	37	alhaitham)/	alhaitham)/	PROPN
iajs-314	4	38	university	university	PROPN
iajs-314	4	39	of	of	ADP
iajs-314	4	40	baghdad	baghdad	PROPN
iajs-314	4	41	received	receive	VERB
iajs-314	4	42	in	in	ADP
iajs-314	4	43	:	:	PUNCT
iajs-314	4	44	22	22	NUM
iajs-314	4	45	june	june	PROPN
iajs-314	4	46	2013	2013	NUM
iajs-314	4	47	,	,	PUNCT
iajs-314	4	48	accepted	accept	VERB
iajs-314	4	49	in:28	in:28	PROPN
iajs-314	4	50	october	october	PROPN
iajs-314	4	51	2014	2014	NUM
iajs-314	4	52	abstract	abstract	ADJ
iajs-314	4	53	interleukin-35	interleukin-35	PROPN
iajs-314	4	54	(	(	PUNCT
iajs-314	4	55	il-35	il-35	NUM
iajs-314	4	56	)	)	PUNCT
iajs-314	4	57	is	be	AUX
iajs-314	4	58	a	a	DET
iajs-314	4	59	novel	novel	ADJ
iajs-314	4	60	anti	anti	ADJ
iajs-314	4	61	-	-	ADJ
iajs-314	4	62	inflammatory	inflammatory	ADJ
iajs-314	4	63	of	of	ADP
iajs-314	4	64	il-12	il-12	DET
iajs-314	4	65	family	family	NOUN
iajs-314	4	66	member	member	NOUN
iajs-314	4	67	cytokine	cytokine	NOUN
iajs-314	4	68	.	.	PUNCT
iajs-314	5	1	high	high	ADJ
iajs-314	5	2	sensitive	sensitive	ADJ
iajs-314	5	3	creactive	creactive	ADJ
iajs-314	5	4	protein	protein	NOUN
iajs-314	5	5	(	(	PUNCT
iajs-314	5	6	hs	hs	NOUN
iajs-314	5	7	-	-	PROPN
iajs-314	5	8	crp	crp	NOUN
iajs-314	5	9	)	)	PUNCT
iajs-314	5	10	is	be	AUX
iajs-314	5	11	a	a	DET
iajs-314	5	12	marker	marker	NOUN
iajs-314	5	13	of	of	ADP
iajs-314	5	14	inflammation	inflammation	NOUN
iajs-314	5	15	disease	disease	NOUN
iajs-314	5	16	.	.	PUNCT
iajs-314	6	1	this	this	DET
iajs-314	6	2	study	study	NOUN
iajs-314	6	3	was	be	AUX
iajs-314	6	4	obtained	obtain	VERB
iajs-314	6	5	to	to	PART
iajs-314	6	6	estimate	estimate	VERB
iajs-314	6	7	the	the	DET
iajs-314	6	8	concentrations	concentration	NOUN
iajs-314	6	9	of	of	ADP
iajs-314	6	10	il-35	il-35	ADP
iajs-314	6	11	and	and	CCONJ
iajs-314	6	12	hs	hs	PROPN
iajs-314	6	13	-	-	PROPN
iajs-314	6	14	crp	crp	NOUN
iajs-314	6	15	in	in	ADP
iajs-314	6	16	cardiovascular	cardiovascular	ADJ
iajs-314	6	17	diseases	disease	NOUN
iajs-314	6	18	iraqi	iraqi	ADJ
iajs-314	6	19	patients	patient	NOUN
iajs-314	6	20	.	.	PUNCT
iajs-314	7	1	the	the	DET
iajs-314	7	2	study	study	NOUN
iajs-314	7	3	contained	contain	VERB
iajs-314	7	4	79	79	NUM
iajs-314	7	5	subjects	subject	NOUN
iajs-314	7	6	divided	divide	VERB
iajs-314	7	7	into	into	ADP
iajs-314	7	8	two	two	NUM
iajs-314	7	9	groups	group	NOUN
iajs-314	7	10	,	,	PUNCT
iajs-314	7	11	47	47	NUM
iajs-314	7	12	(	(	PUNCT
iajs-314	7	13	21	21	NUM
iajs-314	7	14	male	male	NOUN
iajs-314	7	15	and	and	CCONJ
iajs-314	7	16	26	26	NUM
iajs-314	7	17	female	female	NOUN
iajs-314	7	18	)	)	PUNCT
iajs-314	7	19	suffering	suffer	VERB
iajs-314	7	20	from	from	ADP
iajs-314	7	21	cardiovascular	cardiovascular	ADJ
iajs-314	7	22	diseases	disease	NOUN
iajs-314	7	23	and	and	CCONJ
iajs-314	7	24	32	32	NUM
iajs-314	7	25	as	as	ADP
iajs-314	7	26	control	control	NOUN
iajs-314	7	27	group	group	NOUN
iajs-314	7	28	.	.	PUNCT
iajs-314	8	1	the	the	DET
iajs-314	8	2	concentration	concentration	NOUN
iajs-314	8	3	of	of	ADP
iajs-314	8	4	il-35	il-35	ADP
iajs-314	8	5	and	and	CCONJ
iajs-314	8	6	hs	hs	PROPN
iajs-314	8	7	-	-	PROPN
iajs-314	8	8	crp	crp	PROPN
iajs-314	8	9	was	be	AUX
iajs-314	8	10	measured	measure	VERB
iajs-314	8	11	by	by	ADP
iajs-314	8	12	enzymelinked	enzymelinke	VERB
iajs-314	8	13	immune	immune	ADJ
iajs-314	8	14	sorbent	sorbent	NOUN
iajs-314	8	15	assay	assay	NOUN
iajs-314	8	16	(	(	PUNCT
iajs-314	8	17	elisa	elisa	NOUN
iajs-314	8	18	)	)	PUNCT
iajs-314	8	19	.	.	PUNCT
iajs-314	9	1	the	the	DET
iajs-314	9	2	results	result	NOUN
iajs-314	9	3	revealed	reveal	VERB
iajs-314	9	4	that	that	SCONJ
iajs-314	9	5	the	the	DET
iajs-314	9	6	concentrations	concentration	NOUN
iajs-314	9	7	of	of	ADP
iajs-314	9	8	il-35	il-35	ADP
iajs-314	9	9	and	and	CCONJ
iajs-314	9	10	hs	hs	PROPN
iajs-314	9	11	-	-	PROPN
iajs-314	9	12	crp	crp	PROPN
iajs-314	9	13	are	be	AUX
iajs-314	9	14	increased	increase	VERB
iajs-314	9	15	in	in	ADP
iajs-314	9	16	patients	patient	NOUN
iajs-314	9	17	group	group	NOUN
iajs-314	9	18	.	.	PUNCT
iajs-314	10	1	il-35	il-35	PROPN
iajs-314	10	2	is	be	AUX
iajs-314	10	3	strongly	strongly	ADV
iajs-314	10	4	expressed	express	VERB
iajs-314	10	5	in	in	ADP
iajs-314	10	6	human	human	ADJ
iajs-314	10	7	advanced	advanced	ADJ
iajs-314	10	8	plaque	plaque	NOUN
iajs-314	10	9	and	and	CCONJ
iajs-314	10	10	hs	hs	PROPN
iajs-314	10	11	-	-	PROPN
iajs-314	10	12	crp	crp	PROPN
iajs-314	10	13	.	.	PUNCT
iajs-314	11	1	therefore	therefore	ADV
iajs-314	11	2	these	these	DET
iajs-314	11	3	two	two	NUM
iajs-314	11	4	biomarkers	biomarker	NOUN
iajs-314	11	5	could	could	AUX
iajs-314	11	6	be	be	AUX
iajs-314	11	7	useful	useful	ADJ
iajs-314	11	8	as	as	ADP
iajs-314	11	9	addition	addition	NOUN
iajs-314	11	10	in	in	ADP
iajs-314	11	11	diagnosis	diagnosis	NOUN
iajs-314	11	12	of	of	ADP
iajs-314	11	13	cardiovascular	cardiovascular	ADJ
iajs-314	11	14	diseases	disease	NOUN
iajs-314	11	15	.	.	PUNCT
iajs-314	12	1	a	a	DET
iajs-314	12	2	significant	significant	ADJ
iajs-314	12	3	increase	increase	NOUN
iajs-314	12	4	of	of	ADP
iajs-314	12	5	il-35	il-35	ADP
iajs-314	12	6	and	and	CCONJ
iajs-314	12	7	hs	hs	PROPN
iajs-314	12	8	-	-	PROPN
iajs-314	12	9	crp	crp	PROPN
iajs-314	12	10	levels	level	NOUN
iajs-314	12	11	in	in	ADP
iajs-314	12	12	patients	patient	NOUN
iajs-314	12	13	group	group	NOUN
iajs-314	12	14	compared	compare	VERB
iajs-314	12	15	with	with	ADP
iajs-314	12	16	controls	control	NOUN
iajs-314	12	17	(	(	PUNCT
iajs-314	12	18	p<0.005	p<0.005	NOUN
iajs-314	12	19	)	)	PUNCT
iajs-314	12	20	and	and	CCONJ
iajs-314	12	21	there	there	PRON
iajs-314	12	22	was	be	VERB
iajs-314	12	23	a	a	DET
iajs-314	12	24	positive	positive	ADJ
iajs-314	12	25	correlation	correlation	NOUN
iajs-314	12	26	between	between	ADP
iajs-314	12	27	il-35	il-35	PART
iajs-314	12	28	with	with	ADP
iajs-314	12	29	hs	hs	PROPN
iajs-314	12	30	-	-	PROPN
iajs-314	12	31	crp	crp	NOUN
iajs-314	12	32	in	in	ADP
iajs-314	12	33	patients	patient	NOUN
iajs-314	12	34	group	group	NOUN
iajs-314	12	35	.	.	PUNCT
iajs-314	13	1	the	the	DET
iajs-314	13	2	results	result	NOUN
iajs-314	13	3	of	of	ADP
iajs-314	13	4	this	this	DET
iajs-314	13	5	study	study	NOUN
iajs-314	13	6	revealed	reveal	VERB
iajs-314	13	7	that	that	SCONJ
iajs-314	13	8	il-35	il-35	ADP
iajs-314	13	9	is	be	AUX
iajs-314	13	10	a	a	DET
iajs-314	13	11	potentially	potentially	ADV
iajs-314	13	12	anti	anti	ADJ
iajs-314	13	13	-	-	ADJ
iajs-314	13	14	inflammatory	inflammatory	ADJ
iajs-314	13	15	marker	marker	NOUN
iajs-314	13	16	in	in	ADP
iajs-314	13	17	cardiovascular	cardiovascular	ADJ
iajs-314	13	18	diseases	disease	NOUN
iajs-314	13	19	.	.	PUNCT
iajs-314	14	1	key	key	ADJ
iajs-314	14	2	words	word	NOUN
iajs-314	14	3	:	:	PUNCT
iajs-314	14	4	inflammatory	inflammatory	ADJ
iajs-314	14	5	markers	marker	NOUN
iajs-314	14	6	,	,	PUNCT
iajs-314	14	7	il-35	il-35	ADP
iajs-314	14	8	,	,	PUNCT
iajs-314	14	9	hs	hs	PROPN
iajs-314	14	10	-	-	PROPN
iajs-314	14	11	crp	crp	NOUN
iajs-314	14	12	,	,	PUNCT
iajs-314	14	13	cardiovascular	cardiovascular	ADJ
iajs-314	14	14	diseases	disease	NOUN
iajs-314	14	15	,	,	PUNCT
iajs-314	14	16	iraqi	iraqi	ADJ
iajs-314	14	17	patients	patient	NOUN
iajs-314	14	18	.	.	PUNCT
iajs-314	15	1	494	494	NUM
iajs-314	15	2	|	|	ADV
iajs-314	15	3	chemistry	chemistry	NOUN
iajs-314	15	4	2014	2014	NUM
iajs-314	15	5	)	)	PUNCT
iajs-314	15	6	عام	عام	ADP
iajs-314	15	7	3(العدد	3(العدد	NUM
iajs-314	15	8	27المجلد	27المجلد	NUM
iajs-314	15	9	مجلة	مجلة	VERB
iajs-314	15	10	إبن	إبن	NOUN
iajs-314	15	11	الھيثم	الھيثم	NOUN
iajs-314	15	12	للعلوم	للعلوم	NOUN
iajs-314	15	13	الصرفة	الصرفة	NOUN
iajs-314	16	1	و	و	PRON
iajs-314	16	2	التطبيقية	التطبيقية	ADJ
iajs-314	16	3	ibn	ibn	PROPN
iajs-314	16	4	al	al	PROPN
iajs-314	16	5	-	-	PUNCT
iajs-314	16	6	haitham	haitham	PROPN
iajs-314	16	7	jour	jour	X
iajs-314	16	8	.	.	PROPN
iajs-314	16	9	for	for	ADP
iajs-314	16	10	pure	pure	ADJ
iajs-314	16	11	&	&	CCONJ
iajs-314	16	12	appl	appl	PROPN
iajs-314	16	13	.	.	PUNCT
iajs-314	17	1	sci	sci	PROPN
iajs-314	17	2	.	.	PUNCT
iajs-314	17	3	vol	vol	NOUN
iajs-314	17	4	.	.	PROPN
iajs-314	18	1	27	27	NUM
iajs-314	18	2	(	(	PUNCT
iajs-314	18	3	3	3	NUM
iajs-314	18	4	)	)	PUNCT
iajs-314	18	5	2014	2014	NUM
iajs-314	18	6	introduction	introduction	NOUN
iajs-314	18	7	inflammatory	inflammatory	ADJ
iajs-314	18	8	plays	play	VERB
iajs-314	18	9	an	an	DET
iajs-314	18	10	important	important	ADJ
iajs-314	18	11	role	role	NOUN
iajs-314	18	12	in	in	ADP
iajs-314	18	13	the	the	DET
iajs-314	18	14	pathogenesis	pathogenesis	NOUN
iajs-314	18	15	of	of	ADP
iajs-314	18	16	cardiovascular	cardiovascular	ADJ
iajs-314	18	17	disease	disease	NOUN
iajs-314	18	18	and	and	CCONJ
iajs-314	18	19	various	various	ADJ
iajs-314	18	20	studies	study	NOUN
iajs-314	18	21	in	in	ADP
iajs-314	18	22	dicated	dicate	VERB
iajs-314	18	23	that	that	SCONJ
iajs-314	18	24	inflammatory	inflammatory	ADJ
iajs-314	18	25	markers	marker	NOUN
iajs-314	18	26	appear	appear	VERB
iajs-314	18	27	to	to	PART
iajs-314	18	28	be	be	AUX
iajs-314	18	29	protein	protein	NOUN
iajs-314	18	30	of	of	ADP
iajs-314	18	31	cardiovascular	cardiovascular	ADJ
iajs-314	18	32	events	event	NOUN
iajs-314	18	33	such	such	ADJ
iajs-314	18	34	as	as	ADP
iajs-314	18	35	interleukin-6	interleukin-6	NOUN
iajs-314	18	36	,	,	PUNCT
iajs-314	18	37	il-10	il-10	NOUN
iajs-314	18	38	and	and	CCONJ
iajs-314	18	39	c	c	NOUN
iajs-314	18	40	-	-	PUNCT
iajs-314	18	41	reactive	reactive	ADJ
iajs-314	18	42	protein	protein	NOUN
iajs-314	18	43	(	(	PUNCT
iajs-314	18	44	crp)[1	crp)[1	PROPN
iajs-314	18	45	-	-	PUNCT
iajs-314	18	46	5	5	NUM
iajs-314	18	47	]	]	PUNCT
iajs-314	18	48	.	.	PUNCT
iajs-314	19	1	interleukin	interleukin	NOUN
iajs-314	19	2	35	35	NUM
iajs-314	19	3	(	(	PUNCT
iajs-314	19	4	il-35	il-35	NUM
iajs-314	19	5	)	)	PUNCT
iajs-314	19	6	is	be	AUX
iajs-314	19	7	the	the	DET
iajs-314	19	8	newly	newly	ADV
iajs-314	19	9	identified	identify	VERB
iajs-314	19	10	member	member	NOUN
iajs-314	19	11	of	of	ADP
iajs-314	19	12	il-12	il-12	DET
iajs-314	19	13	family[6,7	family[6,7	PROPN
iajs-314	19	14	]	]	PUNCT
iajs-314	19	15	.	.	PUNCT
iajs-314	20	1	il-35	il-35	PROPN
iajs-314	20	2	is	be	AUX
iajs-314	20	3	a	a	DET
iajs-314	20	4	heterodimeric	heterodimeric	ADJ
iajs-314	20	5	cytokine	cytokine	NOUN
iajs-314	20	6	composed	compose	VERB
iajs-314	20	7	of	of	ADP
iajs-314	20	8	p35	p35	ADJ
iajs-314	20	9	subunit	subunit	NOUN
iajs-314	20	10	of	of	ADP
iajs-314	20	11	il-12α	il-12α	NOUN
iajs-314	20	12	and	and	CCONJ
iajs-314	20	13	the	the	DET
iajs-314	20	14	epstein	epstein	PROPN
iajs-314	20	15	-	-	PUNCT
iajs-314	20	16	bar	bar	NOUN
iajs-314	20	17	virus	virus	NOUN
iajs-314	20	18	induced	induce	VERB
iajs-314	20	19	gene3	gene3	NOUN
iajs-314	20	20	(	(	PUNCT
iajs-314	20	21	ebi3)[7,8	ebi3)[7,8	PROPN
iajs-314	20	22	]	]	PUNCT
iajs-314	20	23	.	.	PUNCT
iajs-314	21	1	ebi3	ebi3	PROPN
iajs-314	21	2	is	be	AUX
iajs-314	21	3	expressed	express	VERB
iajs-314	21	4	at	at	ADP
iajs-314	21	5	high	high	ADJ
iajs-314	21	6	levels	level	NOUN
iajs-314	21	7	in	in	ADP
iajs-314	21	8	human	human	PROPN
iajs-314	21	9	b	b	PROPN
iajs-314	21	10	lymphoblast	lymphoblast	NOUN
iajs-314	21	11	cells	cell	NOUN
iajs-314	21	12	,	,	PUNCT
iajs-314	21	13	tonsils	tonsil	NOUN
iajs-314	21	14	and	and	CCONJ
iajs-314	21	15	spleen	spleen	NOUN
iajs-314	21	16	[	[	X
iajs-314	21	17	9	9	NUM
iajs-314	21	18	]	]	PUNCT
iajs-314	21	19	.	.	PUNCT
iajs-314	22	1	il-35	il-35	PROPN
iajs-314	22	2	is	be	AUX
iajs-314	22	3	secreted	secrete	VERB
iajs-314	22	4	by	by	ADP
iajs-314	22	5	cd4	cd4	PROPN
iajs-314	22	6	+	+	PROPN
iajs-314	22	7	regulatory	regulatory	ADJ
iajs-314	22	8	t	t	NOUN
iajs-314	22	9	(	(	PUNCT
iajs-314	22	10	treg	treg	PROPN
iajs-314	22	11	)	)	PUNCT
iajs-314	22	12	cells	cell	NOUN
iajs-314	22	13	rather	rather	ADV
iajs-314	22	14	than	than	ADP
iajs-314	22	15	cd4	cd4	PROPN
iajs-314	22	16	+	+	PROPN
iajs-314	22	17	effector	effector	NOUN
iajs-314	22	18	t	t	PROPN
iajs-314	22	19	(	(	PUNCT
iajs-314	22	20	teff	teff	NOUN
iajs-314	22	21	)	)	PUNCT
iajs-314	22	22	cells	cell	NOUN
iajs-314	22	23	in	in	ADP
iajs-314	22	24	mice	mouse	NOUN
iajs-314	22	25	;	;	PUNCT
iajs-314	22	26	therefore	therefore	ADV
iajs-314	22	27	,	,	PUNCT
iajs-314	22	28	il-35	il-35	PROPN
iajs-314	22	29	has	have	AUX
iajs-314	22	30	been	be	AUX
iajs-314	22	31	considered	consider	VERB
iajs-314	22	32	to	to	PART
iajs-314	22	33	be	be	AUX
iajs-314	22	34	the	the	DET
iajs-314	22	35	characteristic	characteristic	ADJ
iajs-314	22	36	factor	factor	NOUN
iajs-314	22	37	of	of	ADP
iajs-314	22	38	treg	treg	PROPN
iajs-314	22	39	cells[10–13	cells[10–13	PROPN
iajs-314	22	40	]	]	PUNCT
iajs-314	22	41	.	.	PUNCT
iajs-314	23	1	human	human	ADJ
iajs-314	23	2	treg	treg	PROPN
iajs-314	23	3	cells	cell	NOUN
iajs-314	23	4	,	,	PUNCT
iajs-314	23	5	placental	placental	ADJ
iajs-314	23	6	trophoblast	trophoblast	ADJ
iajs-314	23	7	cells	cell	NOUN
iajs-314	23	8	,	,	PUNCT
iajs-314	23	9	endothelial	endothelial	ADJ
iajs-314	23	10	celss	celss	NOUN
iajs-314	23	11	,	,	PUNCT
iajs-314	23	12	activated	activate	VERB
iajs-314	23	13	dendritic	dendritic	ADJ
iajs-314	23	14	cells	cell	NOUN
iajs-314	23	15	,	,	PUNCT
iajs-314	23	16	and	and	CCONJ
iajs-314	23	17	macrophages	macrophage	NOUN
iajs-314	23	18	also	also	ADV
iajs-314	23	19	express	express	VERB
iajs-314	23	20	il-35[14,15	il-35[14,15	NOUN
iajs-314	23	21	]	]	PUNCT
iajs-314	23	22	.	.	PUNCT
iajs-314	24	1	additional	additional	ADJ
iajs-314	24	2	evidence	evidence	NOUN
iajs-314	24	3	demonstrated	demonstrate	VERB
iajs-314	24	4	that	that	SCONJ
iajs-314	24	5	il-35	il-35	ADP
iajs-314	24	6	is	be	AUX
iajs-314	24	7	an	an	DET
iajs-314	24	8	important	important	ADJ
iajs-314	24	9	anti	anti	ADJ
iajs-314	24	10	-	-	ADJ
iajs-314	24	11	inflammatory	inflammatory	ADJ
iajs-314	24	12	cytokine	cytokine	NOUN
iajs-314	24	13	and	and	CCONJ
iajs-314	24	14	can	can	AUX
iajs-314	24	15	efficiently	efficiently	ADV
iajs-314	24	16	suppress	suppress	VERB
iajs-314	24	17	the	the	DET
iajs-314	24	18	teff	teff	NOUN
iajs-314	24	19	cell	cell	NOUN
iajs-314	24	20	(	(	PUNCT
iajs-314	24	21	including	include	VERB
iajs-314	24	22	th1	th1	PROPN
iajs-314	24	23	,	,	PUNCT
iajs-314	24	24	th2	th2	PROPN
iajs-314	24	25	and	and	CCONJ
iajs-314	24	26	th17	th17	PROPN
iajs-314	24	27	)	)	PUNCT
iajs-314	24	28	activity	activity	NOUN
iajs-314	24	29	and	and	CCONJ
iajs-314	24	30	reduce	reduce	VERB
iajs-314	24	31	the	the	DET
iajs-314	24	32	progression	progression	NOUN
iajs-314	24	33	of	of	ADP
iajs-314	24	34	inflammatory	inflammatory	ADJ
iajs-314	24	35	diseases	disease	NOUN
iajs-314	24	36	and	and	CCONJ
iajs-314	24	37	autoimmune	autoimmune	ADJ
iajs-314	24	38	diseases	disease	NOUN
iajs-314	25	1	[	[	X
iajs-314	25	2	6,7,16,17	6,7,16,17	NOUN
iajs-314	25	3	]	]	PUNCT
iajs-314	25	4	.	.	PUNCT
iajs-314	26	1	c	c	X
iajs-314	26	2	-	-	PUNCT
iajs-314	26	3	reactive	reactive	ADJ
iajs-314	26	4	protein	protein	NOUN
iajs-314	26	5	(	(	PUNCT
iajs-314	26	6	crp	crp	PROPN
iajs-314	26	7	)	)	PUNCT
iajs-314	26	8	is	be	AUX
iajs-314	26	9	the	the	DET
iajs-314	26	10	prototype	prototype	NOUN
iajs-314	26	11	acute	acute	NOUN
iajs-314	26	12	phase	phase	NOUN
iajs-314	26	13	protein	protein	NOUN
iajs-314	26	14	primarily	primarily	ADV
iajs-314	26	15	synthesized	synthesize	VERB
iajs-314	26	16	in	in	ADP
iajs-314	26	17	liver	liver	NOUN
iajs-314	26	18	and	and	CCONJ
iajs-314	26	19	its	its	PRON
iajs-314	26	20	release	release	NOUN
iajs-314	26	21	is	be	AUX
iajs-314	26	22	stimulated	stimulate	VERB
iajs-314	26	23	by	by	ADP
iajs-314	26	24	interleukin6	interleukin6	PROPN
iajs-314	26	25	(	(	PUNCT
iajs-314	26	26	il-6	il-6	NOUN
iajs-314	26	27	)	)	PUNCT
iajs-314	26	28	and	and	CCONJ
iajs-314	26	29	other	other	ADJ
iajs-314	26	30	pro	pro	ADJ
iajs-314	26	31	inflammatory	inflammatory	ADJ
iajs-314	26	32	cytokines[18	cytokines[18	NOUN
iajs-314	26	33	]	]	PUNCT
iajs-314	26	34	.	.	PUNCT
iajs-314	27	1	it	it	PRON
iajs-314	27	2	is	be	AUX
iajs-314	27	3	composed	compose	VERB
iajs-314	27	4	of	of	ADP
iajs-314	27	5	five	five	NUM
iajs-314	27	6	identical	identical	ADJ
iajs-314	27	7	non	non	ADJ
iajs-314	27	8	-	-	ADJ
iajs-314	27	9	glycosylated	glycosylated	ADJ
iajs-314	27	10	polypeptide	polypeptide	ADJ
iajs-314	27	11	subunits	subunit	NOUN
iajs-314	27	12	each	each	PRON
iajs-314	27	13	containing	contain	VERB
iajs-314	27	14	206	206	NUM
iajs-314	27	15	amino	amino	NOUN
iajs-314	27	16	acid	acid	NOUN
iajs-314	27	17	residues	residue	NOUN
iajs-314	27	18	.	.	PUNCT
iajs-314	28	1	crp	crp	PROPN
iajs-314	28	2	is	be	AUX
iajs-314	28	3	a	a	DET
iajs-314	28	4	hepatically	hepatically	ADV
iajs-314	28	5	derived	derive	VERB
iajs-314	28	6	pentraxin	pentraxin	NOUN
iajs-314	28	7	that	that	PRON
iajs-314	28	8	plays	play	VERB
iajs-314	28	9	a	a	DET
iajs-314	28	10	key	key	ADJ
iajs-314	28	11	role	role	NOUN
iajs-314	28	12	in	in	ADP
iajs-314	28	13	the	the	DET
iajs-314	28	14	innate	innate	ADJ
iajs-314	28	15	immune	immune	ADJ
iajs-314	28	16	response[19,20	response[19,20	NOUN
iajs-314	28	17	]	]	X
iajs-314	28	18	.	.	PUNCT
iajs-314	29	1	epidemiological	epidemiological	ADJ
iajs-314	29	2	studies	study	NOUN
iajs-314	29	3	have	have	AUX
iajs-314	29	4	demonstrated	demonstrate	VERB
iajs-314	29	5	that	that	SCONJ
iajs-314	29	6	c	c	NOUN
iajs-314	29	7	-	-	PUNCT
iajs-314	29	8	reactive	reactive	ADJ
iajs-314	29	9	protein	protein	NOUN
iajs-314	29	10	(	(	PUNCT
iajs-314	29	11	crp	crp	PROPN
iajs-314	29	12	)	)	PUNCT
iajs-314	29	13	is	be	AUX
iajs-314	29	14	a	a	DET
iajs-314	29	15	strong	strong	ADJ
iajs-314	29	16	predictor	predictor	NOUN
iajs-314	29	17	myocardial	myocardial	ADJ
iajs-314	29	18	infarction	infarction	NOUN
iajs-314	30	1	[	[	X
iajs-314	30	2	21	21	NUM
iajs-314	30	3	-	-	SYM
iajs-314	30	4	23	23	NUM
iajs-314	30	5	]	]	PUNCT
iajs-314	30	6	,	,	PUNCT
iajs-314	30	7	stroke[21,22,24	stroke[21,22,24	X
iajs-314	30	8	]	]	PUNCT
iajs-314	30	9	sudden	sudden	ADJ
iajs-314	30	10	cardiac	cardiac	ADJ
iajs-314	30	11	death[25	death[25	NOUN
iajs-314	30	12	]	]	X
iajs-314	30	13	,	,	PUNCT
iajs-314	30	14	and	and	CCONJ
iajs-314	30	15	peripheral	peripheral	ADJ
iajs-314	30	16	arterial	arterial	ADJ
iajs-314	30	17	disease[24	disease[24	NOUN
iajs-314	30	18	]	]	PUNCT
iajs-314	30	19	in	in	ADP
iajs-314	30	20	apparently	apparently	ADV
iajs-314	30	21	healthy	healthy	ADJ
iajs-314	30	22	adults	adult	NOUN
iajs-314	30	23	.	.	PUNCT
iajs-314	31	1	high	high	ADJ
iajs-314	31	2	sensitive	sensitive	ADJ
iajs-314	31	3	crp	crp	PROPN
iajs-314	31	4	(	(	PUNCT
iajs-314	31	5	hs	hs	PROPN
iajs-314	31	6	-	-	PROPN
iajs-314	31	7	crp	crp	NOUN
iajs-314	31	8	)	)	PUNCT
iajs-314	31	9	is	be	AUX
iajs-314	31	10	a	a	DET
iajs-314	31	11	marker	marker	NOUN
iajs-314	31	12	of	of	ADP
iajs-314	31	13	low	low	ADJ
iajs-314	31	14	grade	grade	NOUN
iajs-314	31	15	chronic	chronic	ADJ
iajs-314	31	16	system	system	NOUN
iajs-314	31	17	inflammation	inflammation	NOUN
iajs-314	31	18	and	and	CCONJ
iajs-314	31	19	it	it	PRON
iajs-314	31	20	can	can	AUX
iajs-314	31	21	amplify	amplify	VERB
iajs-314	31	22	the	the	DET
iajs-314	31	23	anti	anti	ADJ
iajs-314	31	24	-	-	ADJ
iajs-314	31	25	inflammatory	inflammatory	ADJ
iajs-314	31	26	response	response	NOUN
iajs-314	31	27	through	through	ADP
iajs-314	31	28	complement	complement	NOUN
iajs-314	31	29	activation	activation	NOUN
iajs-314	31	30	,	,	PUNCT
iajs-314	31	31	tissue	tissue	NOUN
iajs-314	31	32	damage	damage	NOUN
iajs-314	31	33	,	,	PUNCT
iajs-314	31	34	and	and	CCONJ
iajs-314	31	35	activation	activation	NOUN
iajs-314	31	36	of	of	ADP
iajs-314	31	37	endothelial	endothelial	ADJ
iajs-314	31	38	cells	cell	NOUN
iajs-314	31	39	[	[	X
iajs-314	31	40	26	26	NUM
iajs-314	31	41	-	-	SYM
iajs-314	31	42	28	28	NUM
iajs-314	31	43	]	]	PUNCT
iajs-314	31	44	.	.	PUNCT
iajs-314	32	1	there	there	PRON
iajs-314	32	2	is	be	VERB
iajs-314	32	3	no	no	DET
iajs-314	32	4	information	information	NOUN
iajs-314	32	5	mentioned	mention	VERB
iajs-314	32	6	to	to	ADP
iajs-314	32	7	the	the	DET
iajs-314	32	8	relationship	relationship	NOUN
iajs-314	32	9	between	between	ADP
iajs-314	32	10	the	the	DET
iajs-314	32	11	levels	level	NOUN
iajs-314	32	12	of	of	ADP
iajs-314	32	13	plasma	plasma	NOUN
iajs-314	32	14	il-35	il-35	ADP
iajs-314	32	15	and	and	CCONJ
iajs-314	32	16	its	its	PRON
iajs-314	32	17	potential	potential	ADJ
iajs-314	32	18	role	role	NOUN
iajs-314	32	19	in	in	ADP
iajs-314	32	20	cardiovascular	cardiovascular	ADJ
iajs-314	32	21	disease	disease	NOUN
iajs-314	32	22	for	for	ADP
iajs-314	32	23	iraqi	iraqi	ADJ
iajs-314	32	24	patients	patient	NOUN
iajs-314	32	25	.	.	PUNCT
iajs-314	33	1	this	this	DET
iajs-314	33	2	present	present	ADJ
iajs-314	33	3	study	study	NOUN
iajs-314	33	4	was	be	AUX
iajs-314	33	5	carried	carry	VERB
iajs-314	33	6	out	out	ADP
iajs-314	33	7	to	to	PART
iajs-314	33	8	assess	assess	VERB
iajs-314	33	9	the	the	DET
iajs-314	33	10	levels	level	NOUN
iajs-314	33	11	of	of	ADP
iajs-314	33	12	serum	serum	NOUN
iajs-314	33	13	il-35	il-35	ADP
iajs-314	33	14	in	in	ADP
iajs-314	33	15	heart	heart	NOUN
iajs-314	33	16	diseases	disease	NOUN
iajs-314	33	17	patients	patient	NOUN
iajs-314	33	18	and	and	CCONJ
iajs-314	33	19	the	the	DET
iajs-314	33	20	relationship	relationship	NOUN
iajs-314	33	21	to	to	ADP
iajs-314	33	22	other	other	ADJ
iajs-314	33	23	parameters	parameter	NOUN
iajs-314	33	24	,	,	PUNCT
iajs-314	33	25	including	include	VERB
iajs-314	33	26	hs	hs	PROPN
iajs-314	33	27	-	-	PROPN
iajs-314	33	28	crp	crp	PROPN
iajs-314	33	29	and	and	CCONJ
iajs-314	33	30	total	total	ADJ
iajs-314	33	31	cholesterol	cholesterol	NOUN
iajs-314	33	32	(	(	PUNCT
iajs-314	33	33	tc	tc	NOUN
iajs-314	33	34	)	)	PUNCT
iajs-314	33	35	.	.	PUNCT
iajs-314	34	1	methods	method	NOUN
iajs-314	34	2	the	the	DET
iajs-314	34	3	study	study	NOUN
iajs-314	34	4	consisted	consist	VERB
iajs-314	34	5	of	of	ADP
iajs-314	34	6	79	79	NUM
iajs-314	34	7	subjects	subject	NOUN
iajs-314	34	8	divided	divide	VERB
iajs-314	34	9	into	into	ADP
iajs-314	34	10	two	two	NUM
iajs-314	34	11	groups	group	NOUN
iajs-314	34	12	,	,	PUNCT
iajs-314	34	13	47	47	NUM
iajs-314	34	14	subjects	subject	NOUN
iajs-314	34	15	(	(	PUNCT
iajs-314	34	16	21male	21male	NUM
iajs-314	34	17	and	and	CCONJ
iajs-314	34	18	26	26	NUM
iajs-314	34	19	female	female	NOUN
iajs-314	34	20	,	,	PUNCT
iajs-314	34	21	range	range	NOUN
iajs-314	34	22	age	age	NOUN
iajs-314	34	23	48	48	NUM
iajs-314	34	24	-	-	SYM
iajs-314	34	25	68	68	NUM
iajs-314	34	26	years	year	NOUN
iajs-314	34	27	)	)	PUNCT
iajs-314	34	28	suffering	suffer	VERB
iajs-314	34	29	from	from	ADP
iajs-314	34	30	cardiovascular	cardiovascular	ADJ
iajs-314	34	31	diseases	disease	NOUN
iajs-314	34	32	.	.	PUNCT
iajs-314	35	1	the	the	DET
iajs-314	35	2	other	other	ADJ
iajs-314	35	3	32	32	NUM
iajs-314	35	4	health	health	NOUN
iajs-314	35	5	were	be	AUX
iajs-314	35	6	controlled	control	VERB
iajs-314	35	7	as	as	ADP
iajs-314	35	8	control	control	NOUN
iajs-314	35	9	group	group	NOUN
iajs-314	35	10	(	(	PUNCT
iajs-314	35	11	male	male	NOUN
iajs-314	35	12	13	13	NUM
iajs-314	35	13	and	and	CCONJ
iajs-314	35	14	19	19	NUM
iajs-314	35	15	female	female	NOUN
iajs-314	35	16	,	,	PUNCT
iajs-314	35	17	range	range	NOUN
iajs-314	35	18	age	age	NOUN
iajs-314	35	19	4465	4465	NUM
iajs-314	35	20	years	year	NOUN
iajs-314	35	21	)	)	PUNCT
iajs-314	35	22	.	.	PUNCT
iajs-314	36	1	the	the	DET
iajs-314	36	2	patients	patient	NOUN
iajs-314	36	3	were	be	AUX
iajs-314	36	4	taken	take	VERB
iajs-314	36	5	from	from	ADP
iajs-314	36	6	ccu	ccu	PROPN
iajs-314	36	7	unit	unit	NOUN
iajs-314	36	8	in	in	ADP
iajs-314	36	9	al	al	PROPN
iajs-314	36	10	-	-	PUNCT
iajs-314	36	11	kadymia	kadymia	PROPN
iajs-314	36	12	teaching	teaching	NOUN
iajs-314	36	13	hospital	hospital	NOUN
iajs-314	36	14	for	for	ADP
iajs-314	36	15	period	period	NOUN
iajs-314	36	16	from	from	ADP
iajs-314	36	17	january	january	PROPN
iajs-314	36	18	to	to	ADP
iajs-314	36	19	april	april	PROPN
iajs-314	36	20	,	,	PUNCT
iajs-314	36	21	while	while	SCONJ
iajs-314	36	22	the	the	DET
iajs-314	36	23	healthy	healthy	ADJ
iajs-314	36	24	controls	control	NOUN
iajs-314	36	25	were	be	AUX
iajs-314	36	26	volunteers	volunteer	NOUN
iajs-314	36	27	.	.	PUNCT
iajs-314	37	1	blood	blood	NOUN
iajs-314	37	2	samples	sample	NOUN
iajs-314	37	3	(	(	PUNCT
iajs-314	37	4	5	5	NUM
iajs-314	37	5	ml	ml	NOUN
iajs-314	37	6	)	)	PUNCT
iajs-314	37	7	were	be	AUX
iajs-314	37	8	drawn	draw	VERB
iajs-314	37	9	from	from	ADP
iajs-314	37	10	patients	patient	NOUN
iajs-314	37	11	and	and	CCONJ
iajs-314	37	12	controls	control	NOUN
iajs-314	37	13	.	.	PUNCT
iajs-314	38	1	the	the	DET
iajs-314	38	2	levels	level	NOUN
iajs-314	38	3	of	of	ADP
iajs-314	38	4	serum	serum	NOUN
iajs-314	38	5	il-35	il-35	ADP
iajs-314	38	6	and	and	CCONJ
iajs-314	38	7	hs	hs	PROPN
iajs-314	38	8	-	-	PROPN
iajs-314	38	9	crp	crp	PROPN
iajs-314	38	10	were	be	AUX
iajs-314	38	11	measured	measure	VERB
iajs-314	38	12	by	by	ADP
iajs-314	38	13	using	use	VERB
iajs-314	38	14	an	an	DET
iajs-314	38	15	enzymelinked	enzymelinke	VERB
iajs-314	38	16	immune	immune	ADJ
iajs-314	38	17	sorbent	sorbent	NOUN
iajs-314	38	18	assay	assay	NOUN
iajs-314	38	19	(	(	PUNCT
iajs-314	38	20	elisa	elisa	NOUN
iajs-314	38	21	)	)	PUNCT
iajs-314	38	22	,	,	PUNCT
iajs-314	38	23	according	accord	VERB
iajs-314	38	24	to	to	ADP
iajs-314	38	25	the	the	DET
iajs-314	38	26	manufacturer	manufacturer	NOUN
iajs-314	38	27	’s	’s	PART
iajs-314	38	28	instructions	instruction	NOUN
iajs-314	38	29	(	(	PUNCT
iajs-314	38	30	cusabbio	cusabbio	NOUN
iajs-314	38	31	)	)	PUNCT
iajs-314	38	32	and	and	CCONJ
iajs-314	38	33	(	(	PUNCT
iajs-314	38	34	drg	drg	NOUN
iajs-314	38	35	)	)	PUNCT
iajs-314	38	36	respectively	respectively	ADV
iajs-314	38	37	.	.	PUNCT
iajs-314	39	1	serum	serum	PROPN
iajs-314	39	2	total	total	ADJ
iajs-314	39	3	cholesterol	cholesterol	NOUN
iajs-314	39	4	(	(	PUNCT
iajs-314	39	5	tc	tc	NOUN
iajs-314	39	6	)	)	PUNCT
iajs-314	39	7	was	be	AUX
iajs-314	39	8	estimated	estimate	VERB
iajs-314	39	9	by	by	ADP
iajs-314	39	10	commercially	commercially	ADV
iajs-314	39	11	available	available	ADJ
iajs-314	39	12	kit	kit	NOUN
iajs-314	39	13	from	from	ADP
iajs-314	39	14	biosystems	biosystem	NOUN
iajs-314	39	15	.	.	PUNCT
iajs-314	40	1	it	it	PRON
iajs-314	40	2	was	be	AUX
iajs-314	40	3	estimated	estimate	VERB
iajs-314	40	4	by	by	ADP
iajs-314	40	5	enzymatic	enzymatic	ADJ
iajs-314	40	6	method	method	NOUN
iajs-314	40	7	.	.	PUNCT
iajs-314	41	1	statistical	statistical	ADJ
iajs-314	41	2	analysis	analysis	NOUN
iajs-314	41	3	all	all	DET
iajs-314	41	4	data	datum	NOUN
iajs-314	41	5	are	be	AUX
iajs-314	41	6	given	give	VERB
iajs-314	41	7	as	as	ADP
iajs-314	41	8	the	the	DET
iajs-314	41	9	mean	mean	ADJ
iajs-314	41	10	±	±	NUM
iajs-314	41	11	sd	sd	NOUN
iajs-314	41	12	and	and	CCONJ
iajs-314	41	13	where	where	SCONJ
iajs-314	41	14	analyzed	analyze	VERB
iajs-314	41	15	by	by	ADP
iajs-314	41	16	an	an	DET
iajs-314	41	17	anova	anova	PROPN
iajs-314	41	18	.	.	PUNCT
iajs-314	42	1	person	person	NOUN
iajs-314	42	2	’s	’s	PART
iajs-314	42	3	correlation	correlation	NOUN
iajs-314	42	4	was	be	AUX
iajs-314	42	5	used	use	VERB
iajs-314	42	6	to	to	PART
iajs-314	42	7	examine	examine	VERB
iajs-314	42	8	the	the	DET
iajs-314	42	9	relation	relation	NOUN
iajs-314	42	10	between	between	ADP
iajs-314	42	11	il-35	il-35	PART
iajs-314	42	12	with	with	ADP
iajs-314	42	13	hs	hs	PROPN
iajs-314	42	14	-	-	PROPN
iajs-314	42	15	crp	crp	PROPN
iajs-314	42	16	and	and	CCONJ
iajs-314	42	17	tc	tc	NOUN
iajs-314	42	18	.	.	PUNCT
iajs-314	43	1	a	a	DET
iajs-314	43	2	value	value	NOUN
iajs-314	43	3	of	of	ADP
iajs-314	43	4	p	p	NOUN
iajs-314	43	5	was	be	AUX
iajs-314	43	6	considered	consider	VERB
iajs-314	43	7	to	to	PART
iajs-314	43	8	be	be	AUX
iajs-314	43	9	statically	statically	ADV
iajs-314	43	10	significant	significant	ADJ
iajs-314	43	11	(	(	PUNCT
iajs-314	43	12	p	p	X
iajs-314	43	13	<	<	X
iajs-314	43	14	0.005	0.005	NUM
iajs-314	43	15	)	)	PUNCT
iajs-314	43	16	.	.	PUNCT
iajs-314	44	1	495	495	NUM
iajs-314	44	2	|	|	ADV
iajs-314	44	3	chemistry	chemistry	NOUN
iajs-314	44	4	2014	2014	NUM
iajs-314	44	5	)	)	PUNCT
iajs-314	44	6	عام	عام	ADP
iajs-314	44	7	3(العدد	3(العدد	NUM
iajs-314	44	8	27المجلد	27المجلد	NUM
iajs-314	44	9	مجلة	مجلة	VERB
iajs-314	44	10	إبن	إبن	NOUN
iajs-314	44	11	الھيثم	الھيثم	NOUN
iajs-314	44	12	للعلوم	للعلوم	NOUN
iajs-314	44	13	الصرفة	الصرفة	NOUN
iajs-314	45	1	و	و	PRON
iajs-314	45	2	التطبيقية	التطبيقية	ADJ
iajs-314	45	3	ibn	ibn	PROPN
iajs-314	45	4	al	al	PROPN
iajs-314	45	5	-	-	PUNCT
iajs-314	45	6	haitham	haitham	PROPN
iajs-314	45	7	jour	jour	X
iajs-314	45	8	.	.	PROPN
iajs-314	45	9	for	for	ADP
iajs-314	45	10	pure	pure	ADJ
iajs-314	45	11	&	&	CCONJ
iajs-314	45	12	appl	appl	PROPN
iajs-314	45	13	.	.	PUNCT
iajs-314	46	1	sci	sci	PROPN
iajs-314	46	2	.	.	PUNCT
iajs-314	46	3	vol	vol	NOUN
iajs-314	46	4	.	.	PROPN
iajs-314	47	1	27	27	NUM
iajs-314	47	2	(	(	PUNCT
iajs-314	47	3	3	3	NUM
iajs-314	47	4	)	)	PUNCT
iajs-314	47	5	2014	2014	NUM
iajs-314	47	6	results	result	VERB
iajs-314	47	7	the	the	DET
iajs-314	47	8	distribution	distribution	NOUN
iajs-314	47	9	of	of	ADP
iajs-314	47	10	sex	sex	NOUN
iajs-314	47	11	,	,	PUNCT
iajs-314	47	12	mean	mean	ADJ
iajs-314	47	13	age	age	NOUN
iajs-314	47	14	and	and	CCONJ
iajs-314	47	15	total	total	ADJ
iajs-314	47	16	cholesterol	cholesterol	NOUN
iajs-314	47	17	for	for	ADP
iajs-314	47	18	patients	patient	NOUN
iajs-314	47	19	and	and	CCONJ
iajs-314	47	20	control	control	NOUN
iajs-314	47	21	groups	group	NOUN
iajs-314	47	22	are	be	AUX
iajs-314	47	23	shown	show	VERB
iajs-314	47	24	in	in	ADP
iajs-314	47	25	table	table	NOUN
iajs-314	47	26	1	1	NUM
iajs-314	47	27	.	.	PUNCT
iajs-314	48	1	the	the	DET
iajs-314	48	2	mean	mean	ADJ
iajs-314	48	3	age	age	NOUN
iajs-314	48	4	was	be	AUX
iajs-314	48	5	(	(	PUNCT
iajs-314	48	6	50±	50±	PROPN
iajs-314	48	7	4.3	4.3	NUM
iajs-314	48	8	)	)	PUNCT
iajs-314	48	9	years	year	NOUN
iajs-314	48	10	in	in	ADP
iajs-314	48	11	iraqi	iraqi	ADJ
iajs-314	48	12	patients	patient	NOUN
iajs-314	48	13	and	and	CCONJ
iajs-314	48	14	(	(	PUNCT
iajs-314	48	15	56±	56±	NUM
iajs-314	48	16	6.9	6.9	NUM
iajs-314	48	17	)	)	PUNCT
iajs-314	48	18	in	in	ADP
iajs-314	48	19	control	control	NOUN
iajs-314	48	20	group	group	NOUN
iajs-314	48	21	.	.	PUNCT
iajs-314	49	1	there	there	PRON
iajs-314	49	2	was	be	VERB
iajs-314	49	3	no	no	DET
iajs-314	49	4	significant	significant	ADJ
iajs-314	49	5	difference	difference	NOUN
iajs-314	49	6	in	in	ADP
iajs-314	49	7	age	age	NOUN
iajs-314	49	8	and	and	CCONJ
iajs-314	49	9	gender	gender	NOUN
iajs-314	49	10	between	between	ADP
iajs-314	49	11	the	the	DET
iajs-314	49	12	iraqi	iraqi	ADJ
iajs-314	49	13	patients	patient	NOUN
iajs-314	49	14	with	with	ADP
iajs-314	49	15	cardiovascular	cardiovascular	ADJ
iajs-314	49	16	diseases	disease	NOUN
iajs-314	49	17	and	and	CCONJ
iajs-314	49	18	control	control	NOUN
iajs-314	49	19	group	group	NOUN
iajs-314	49	20	as	as	ADP
iajs-314	49	21	in	in	ADP
iajs-314	49	22	table	table	NOUN
iajs-314	49	23	1	1	NUM
iajs-314	49	24	.	.	PUNCT
iajs-314	49	25	serum	serum	NOUN
iajs-314	49	26	total	total	ADJ
iajs-314	49	27	cholesterol	cholesterol	NOUN
iajs-314	49	28	showed	show	VERB
iajs-314	49	29	significant	significant	ADJ
iajs-314	49	30	differences	difference	NOUN
iajs-314	49	31	between	between	ADP
iajs-314	49	32	patients	patient	NOUN
iajs-314	49	33	and	and	CCONJ
iajs-314	49	34	control	control	NOUN
iajs-314	49	35	groups	group	NOUN
iajs-314	49	36	(	(	PUNCT
iajs-314	49	37	p	p	X
iajs-314	49	38	<	<	X
iajs-314	49	39	0.005	0.005	NUM
iajs-314	49	40	)	)	PUNCT
iajs-314	49	41	.	.	PUNCT
iajs-314	50	1	mean	mean	ADJ
iajs-314	50	2	value	value	NOUN
iajs-314	50	3	of	of	ADP
iajs-314	50	4	serum	serum	NOUN
iajs-314	50	5	total	total	ADJ
iajs-314	50	6	cholesterol	cholesterol	NOUN
iajs-314	50	7	(	(	PUNCT
iajs-314	50	8	tc	tc	NOUN
iajs-314	50	9	)	)	PUNCT
iajs-314	50	10	was	be	AUX
iajs-314	50	11	228.6	228.6	NUM
iajs-314	50	12	±	±	NUM
iajs-314	50	13	21.05	21.05	NUM
iajs-314	50	14	mg/	mg/	NOUN
iajs-314	50	15	dl	dl	PROPN
iajs-314	50	16	in	in	ADP
iajs-314	50	17	patients	patient	NOUN
iajs-314	50	18	group	group	NOUN
iajs-314	50	19	while	while	SCONJ
iajs-314	50	20	in	in	ADP
iajs-314	50	21	control	control	NOUN
iajs-314	50	22	group	group	NOUN
iajs-314	50	23	it	it	PRON
iajs-314	50	24	was	be	AUX
iajs-314	50	25	175.34	175.34	NUM
iajs-314	50	26	±	±	NUM
iajs-314	50	27	12.05	12.05	NUM
iajs-314	50	28	mg/	mg/	PROPN
iajs-314	50	29	dl	dl	PROPN
iajs-314	50	30	.	.	PROPN
iajs-314	50	31	table	table	NOUN
iajs-314	50	32	2	2	NUM
iajs-314	50	33	showed	show	VERB
iajs-314	50	34	mean	mean	ADJ
iajs-314	50	35	value	value	NOUN
iajs-314	50	36	of	of	ADP
iajs-314	50	37	serum	serum	NOUN
iajs-314	50	38	il-35	il-35	ADP
iajs-314	50	39	for	for	ADP
iajs-314	50	40	patients	patient	NOUN
iajs-314	50	41	and	and	CCONJ
iajs-314	50	42	healthy	healthy	ADJ
iajs-314	50	43	control	control	NOUN
iajs-314	50	44	groups	group	NOUN
iajs-314	50	45	which	which	PRON
iajs-314	50	46	it	it	PRON
iajs-314	50	47	was	be	AUX
iajs-314	50	48	36.21	36.21	NUM
iajs-314	50	49	±	±	NUM
iajs-314	50	50	3.52	3.52	NUM
iajs-314	50	51	pg/	pg/	NOUN
iajs-314	50	52	dl	dl	PROPN
iajs-314	50	53	and	and	CCONJ
iajs-314	50	54	22.21	22.21	NUM
iajs-314	50	55	±	±	NUM
iajs-314	50	56	2.01	2.01	NUM
iajs-314	50	57	pg/	pg/	NOUN
iajs-314	50	58	dl	dl	PROPN
iajs-314	50	59	respectively	respectively	ADV
iajs-314	50	60	.	.	PUNCT
iajs-314	51	1	mean	mean	VERB
iajs-314	51	2	values	value	NOUN
iajs-314	51	3	of	of	ADP
iajs-314	51	4	hs	hs	PROPN
iajs-314	51	5	-	-	PROPN
iajs-314	51	6	crp	crp	PROPN
iajs-314	51	7	were	be	AUX
iajs-314	51	8	4.36	4.36	NUM
iajs-314	51	9	±	±	NUM
iajs-314	51	10	0.76	0.76	NUM
iajs-314	51	11	mg/	mg/	NOUN
iajs-314	51	12	l	l	NOUN
iajs-314	51	13	and	and	CCONJ
iajs-314	51	14	0.77	0.77	NUM
iajs-314	51	15	±	±	NUM
iajs-314	51	16	0.25	0.25	NUM
iajs-314	51	17	mg	mg	PROPN
iajs-314	51	18	/	/	SYM
iajs-314	51	19	l	l	NOUN
iajs-314	51	20	for	for	ADP
iajs-314	51	21	patients	patient	NOUN
iajs-314	51	22	and	and	CCONJ
iajs-314	51	23	control	control	NOUN
iajs-314	51	24	groups	group	NOUN
iajs-314	51	25	respectively	respectively	ADV
iajs-314	51	26	.	.	PUNCT
iajs-314	52	1	discussion	discussion	NOUN
iajs-314	52	2	the	the	DET
iajs-314	52	3	levels	level	NOUN
iajs-314	52	4	of	of	ADP
iajs-314	52	5	anti	anti	ADJ
iajs-314	52	6	-	-	ADJ
iajs-314	52	7	inflammatory	inflammatory	ADJ
iajs-314	52	8	cytokine	cytokine	NOUN
iajs-314	52	9	il-35	il-35	ADP
iajs-314	52	10	were	be	AUX
iajs-314	52	11	measured	measure	VERB
iajs-314	52	12	in	in	ADP
iajs-314	52	13	cardiovascular	cardiovascular	ADJ
iajs-314	52	14	diseases	disease	NOUN
iajs-314	52	15	for	for	ADP
iajs-314	52	16	iraqi	iraqi	ADJ
iajs-314	52	17	patients	patient	NOUN
iajs-314	52	18	.	.	PUNCT
iajs-314	53	1	the	the	DET
iajs-314	53	2	results	result	NOUN
iajs-314	53	3	showed	show	VERB
iajs-314	53	4	that	that	SCONJ
iajs-314	53	5	the	the	DET
iajs-314	53	6	elevated	elevated	ADJ
iajs-314	53	7	concentration	concentration	NOUN
iajs-314	53	8	of	of	ADP
iajs-314	53	9	il-35	il-35	NOUN
iajs-314	53	10	was	be	AUX
iajs-314	53	11	associated	associate	VERB
iajs-314	53	12	with	with	ADP
iajs-314	53	13	cardiovascular	cardiovascular	ADJ
iajs-314	53	14	diseases	disease	NOUN
iajs-314	53	15	and	and	CCONJ
iajs-314	53	16	positively	positively	ADV
iajs-314	53	17	correlation	correlation	NOUN
iajs-314	53	18	.	.	PUNCT
iajs-314	54	1	the	the	DET
iajs-314	54	2	levels	level	NOUN
iajs-314	54	3	of	of	ADP
iajs-314	54	4	antiinflammatory	antiinflammatory	NOUN
iajs-314	54	5	cytokine	cytokine	NOUN
iajs-314	54	6	il-35	il-35	ADP
iajs-314	54	7	,	,	PUNCT
iajs-314	54	8	hs	hs	PROPN
iajs-314	54	9	-	-	PROPN
iajs-314	54	10	crp	crp	PROPN
iajs-314	54	11	and	and	CCONJ
iajs-314	54	12	total	total	ADJ
iajs-314	54	13	cholesterol	cholesterol	NOUN
iajs-314	54	14	were	be	AUX
iajs-314	54	15	investigated	investigate	VERB
iajs-314	54	16	in	in	ADP
iajs-314	54	17	cardiovascular	cardiovascular	ADJ
iajs-314	54	18	diseases	disease	NOUN
iajs-314	54	19	for	for	ADP
iajs-314	54	20	iraqi	iraqi	ADJ
iajs-314	54	21	patients	patient	NOUN
iajs-314	54	22	.	.	PUNCT
iajs-314	55	1	the	the	DET
iajs-314	55	2	results	result	NOUN
iajs-314	55	3	showed	show	VERB
iajs-314	55	4	that	that	SCONJ
iajs-314	55	5	the	the	DET
iajs-314	55	6	levels	level	NOUN
iajs-314	55	7	of	of	ADP
iajs-314	55	8	il-35	il-35	ADP
iajs-314	55	9	and	and	CCONJ
iajs-314	55	10	hs	hs	PROPN
iajs-314	55	11	-	-	PROPN
iajs-314	55	12	crp	crp	PROPN
iajs-314	55	13	were	be	AUX
iajs-314	55	14	significantly	significantly	ADV
iajs-314	55	15	higher	high	ADJ
iajs-314	55	16	in	in	ADP
iajs-314	55	17	patients	patient	NOUN
iajs-314	55	18	than	than	ADP
iajs-314	55	19	in	in	ADP
iajs-314	55	20	control	control	NOUN
iajs-314	55	21	group	group	NOUN
iajs-314	55	22	.	.	PUNCT
iajs-314	56	1	the	the	DET
iajs-314	56	2	results	result	NOUN
iajs-314	56	3	showed	show	VERB
iajs-314	56	4	that	that	SCONJ
iajs-314	56	5	higher	high	ADJ
iajs-314	56	6	il-35	il-35	ADP
iajs-314	56	7	levels	level	NOUN
iajs-314	56	8	were	be	AUX
iajs-314	56	9	positively	positively	ADV
iajs-314	56	10	correlated	correlate	VERB
iajs-314	56	11	with	with	ADP
iajs-314	56	12	crp	crp	PROPN
iajs-314	56	13	(	(	PUNCT
iajs-314	56	14	r=	r=	ADJ
iajs-314	56	15	0.11	0.11	NUM
iajs-314	56	16	)	)	PUNCT
iajs-314	56	17	,	,	PUNCT
iajs-314	56	18	(	(	PUNCT
iajs-314	56	19	figure	figure	NOUN
iajs-314	56	20	3	3	NUM
iajs-314	56	21	)	)	PUNCT
iajs-314	56	22	whereas	whereas	SCONJ
iajs-314	56	23	higher	high	ADJ
iajs-314	56	24	tc	tc	NOUN
iajs-314	56	25	levels	level	NOUN
iajs-314	56	26	were	be	AUX
iajs-314	56	27	negatively	negatively	ADV
iajs-314	56	28	correlated	correlate	VERB
iajs-314	56	29	with	with	ADP
iajs-314	56	30	il-35	il-35	ADP
iajs-314	56	31	(	(	PUNCT
iajs-314	56	32	r=	r=	ADJ
iajs-314	56	33	-0.1	-0.1	NOUN
iajs-314	56	34	)	)	PUNCT
iajs-314	56	35	in	in	ADP
iajs-314	56	36	patients	patient	NOUN
iajs-314	56	37	with	with	ADP
iajs-314	56	38	cardiovascular	cardiovascular	ADJ
iajs-314	56	39	diseases	disease	NOUN
iajs-314	56	40	(	(	PUNCT
iajs-314	56	41	figure	figure	NOUN
iajs-314	56	42	4	4	NUM
iajs-314	56	43	)	)	PUNCT
iajs-314	56	44	.	.	PUNCT
iajs-314	57	1	the	the	DET
iajs-314	57	2	serum	serum	NOUN
iajs-314	57	3	anti	anti	ADJ
iajs-314	57	4	-	-	ADJ
iajs-314	57	5	inflammatory	inflammatory	ADJ
iajs-314	57	6	cytokine	cytokine	ADJ
iajs-314	57	7	concentrations	concentration	NOUN
iajs-314	57	8	levels	level	NOUN
iajs-314	57	9	are	be	AUX
iajs-314	57	10	still	still	ADV
iajs-314	57	11	controversial	controversial	ADJ
iajs-314	57	12	.	.	PUNCT
iajs-314	58	1	some	some	DET
iajs-314	58	2	studies	study	NOUN
iajs-314	58	3	observed	observe	VERB
iajs-314	58	4	that	that	SCONJ
iajs-314	58	5	these	these	DET
iajs-314	58	6	levels	level	NOUN
iajs-314	58	7	were	be	AUX
iajs-314	58	8	increased	increase	VERB
iajs-314	58	9	other	other	ADJ
iajs-314	58	10	studies	study	NOUN
iajs-314	58	11	observed	observe	VERB
iajs-314	58	12	significantly	significantly	ADV
iajs-314	58	13	decreased[10	decreased[10	ADV
iajs-314	58	14	-	-	PUNCT
iajs-314	58	15	18,29,30	18,29,30	NUM
iajs-314	58	16	]	]	PUNCT
iajs-314	58	17	.	.	PUNCT
iajs-314	59	1	these	these	DET
iajs-314	59	2	studies	study	NOUN
iajs-314	59	3	indicate	indicate	VERB
iajs-314	59	4	that	that	SCONJ
iajs-314	59	5	the	the	DET
iajs-314	59	6	concentrations	concentration	NOUN
iajs-314	59	7	of	of	ADP
iajs-314	59	8	anti	anti	ADJ
iajs-314	59	9	-	-	ADJ
iajs-314	59	10	inflammatory	inflammatory	ADJ
iajs-314	59	11	cytokines	cytokine	NOUN
iajs-314	59	12	can	can	AUX
iajs-314	59	13	predicate	predicate	VERB
iajs-314	59	14	the	the	DET
iajs-314	59	15	incidence	incidence	NOUN
iajs-314	59	16	of	of	ADP
iajs-314	59	17	cardiovascular	cardiovascular	ADJ
iajs-314	59	18	events	event	NOUN
iajs-314	59	19	.	.	PUNCT
iajs-314	60	1	il-35	il-35	ADP
iajs-314	60	2	is	be	AUX
iajs-314	60	3	an	an	DET
iajs-314	60	4	il-12	il-12	DET
iajs-314	60	5	family	family	NOUN
iajs-314	60	6	member	member	NOUN
iajs-314	60	7	cytokine	cytokine	NOUN
iajs-314	60	8	composed	compose	VERB
iajs-314	60	9	of	of	ADP
iajs-314	60	10	an	an	DET
iajs-314	60	11			NOUN
iajs-314	60	12	chain	chain	NOUN
iajs-314	60	13	p35	p35	NOUN
iajs-314	60	14	and	and	CCONJ
iajs-314	60	15	a	a	DET
iajs-314	60	16			PROPN
iajs-314	60	17	chain	chain	NOUN
iajs-314	60	18	ebi3[6,7	ebi3[6,7	NOUN
iajs-314	60	19	]	]	PUNCT
iajs-314	60	20	.	.	PUNCT
iajs-314	61	1	ebi3	ebi3	PROPN
iajs-314	61	2	and	and	CCONJ
iajs-314	61	3	p35	p35	NOUN
iajs-314	61	4	are	be	AUX
iajs-314	61	5	expressed	express	VERB
iajs-314	61	6	in	in	ADP
iajs-314	61	7	almost	almost	ADV
iajs-314	61	8	all	all	PRON
iajs-314	61	9	advanced	advanced	ADJ
iajs-314	61	10	plaque	plaque	NOUN
iajs-314	61	11	lesions	lesion	NOUN
iajs-314	61	12	and	and	CCONJ
iajs-314	61	13	are	be	AUX
iajs-314	61	14	coexpressed	coexpresse	VERB
iajs-314	61	15	in	in	ADP
iajs-314	61	16	atheroma	atheroma	NOUN
iajs-314	61	17	vascular	vascular	ADJ
iajs-314	61	18	smooth	smooth	ADJ
iajs-314	61	19	muscle	muscle	NOUN
iajs-314	61	20	cell	cell	NOUN
iajs-314	61	21	,	,	PUNCT
iajs-314	61	22	indicating	indicate	VERB
iajs-314	61	23	that	that	SCONJ
iajs-314	61	24	il-35	il-35	ADP
iajs-314	61	25	may	may	AUX
iajs-314	61	26	be	be	AUX
iajs-314	61	27	secreted	secrete	VERB
iajs-314	61	28	by	by	ADP
iajs-314	61	29	vascular	vascular	ADJ
iajs-314	61	30	smooth	smooth	ADJ
iajs-314	61	31	cells	cell	NOUN
iajs-314	61	32	and	and	CCONJ
iajs-314	61	33	is	be	AUX
iajs-314	61	34	involved	involve	VERB
iajs-314	61	35	in	in	ADP
iajs-314	61	36	the	the	DET
iajs-314	61	37	atherosclerosis[3134	atherosclerosis[3134	PROPN
iajs-314	61	38	]	]	PUNCT
iajs-314	61	39	.	.	PUNCT
iajs-314	62	1	in	in	ADP
iajs-314	62	2	addition	addition	NOUN
iajs-314	62	3	,	,	PUNCT
iajs-314	62	4	higher	high	ADJ
iajs-314	62	5	il-35	il-35	ADP
iajs-314	62	6	concentrations	concentration	NOUN
iajs-314	62	7	showed	show	VERB
iajs-314	62	8	a	a	DET
iajs-314	62	9	positive	positive	ADJ
iajs-314	62	10	correlation	correlation	NOUN
iajs-314	62	11	while	while	SCONJ
iajs-314	62	12	higher	high	ADJ
iajs-314	62	13	tc	tc	NOUN
iajs-314	62	14	concentration	concentration	NOUN
iajs-314	62	15	showed	show	VERB
iajs-314	62	16	a	a	DET
iajs-314	62	17	negative	negative	ADJ
iajs-314	62	18	correlation	correlation	NOUN
iajs-314	62	19	with	with	ADP
iajs-314	62	20	il-35	il-35	NOUN
iajs-314	62	21	in	in	ADP
iajs-314	62	22	patients	patient	NOUN
iajs-314	62	23	with	with	ADP
iajs-314	62	24	cardiovascular	cardiovascular	ADJ
iajs-314	62	25	diseases	disease	NOUN
iajs-314	62	26	,	,	PUNCT
iajs-314	62	27	suggestion	suggestion	VERB
iajs-314	62	28	a	a	DET
iajs-314	62	29	potential	potential	ADJ
iajs-314	62	30	role	role	NOUN
iajs-314	62	31	of	of	ADP
iajs-314	62	32	il-35	il-35	NOUN
iajs-314	62	33	in	in	ADP
iajs-314	62	34	prognosis	prognosis	NOUN
iajs-314	62	35	of	of	ADP
iajs-314	62	36	cardiovascular	cardiovascular	ADJ
iajs-314	62	37	diseases	disease	NOUN
iajs-314	62	38	.	.	PUNCT
iajs-314	63	1	it	it	PRON
iajs-314	63	2	was	be	AUX
iajs-314	63	3	found	find	VERB
iajs-314	63	4	that	that	SCONJ
iajs-314	63	5	elevated	elevate	VERB
iajs-314	63	6	hs	hs	PROPN
iajs-314	63	7	-	-	PROPN
iajs-314	63	8	crp	crp	PROPN
iajs-314	63	9	was	be	AUX
iajs-314	63	10	significantly	significantly	ADV
iajs-314	63	11	correlated	correlate	VERB
iajs-314	63	12	with	with	ADP
iajs-314	63	13	coronary	coronary	ADJ
iajs-314	63	14	artery	artery	NOUN
iajs-314	63	15	disease[33,34	disease[33,34	PROPN
iajs-314	63	16	]	]	PUNCT
iajs-314	63	17	.	.	PUNCT
iajs-314	64	1	a	a	DET
iajs-314	64	2	significant	significant	ADJ
iajs-314	64	3	difference	difference	NOUN
iajs-314	64	4	has	have	AUX
iajs-314	64	5	been	be	AUX
iajs-314	64	6	observed	observe	VERB
iajs-314	64	7	regarding	regard	VERB
iajs-314	64	8	the	the	DET
iajs-314	64	9	value	value	NOUN
iajs-314	64	10	of	of	ADP
iajs-314	64	11	hs	hs	PROPN
iajs-314	64	12	-	-	PROPN
iajs-314	64	13	crp	crp	NOUN
iajs-314	64	14	in	in	ADP
iajs-314	64	15	cardiovascular	cardiovascular	ADJ
iajs-314	64	16	disease	disease	NOUN
iajs-314	64	17	subjects	subject	NOUN
iajs-314	64	18	compared	compare	VERB
iajs-314	64	19	to	to	ADP
iajs-314	64	20	normal	normal	ADJ
iajs-314	64	21	subjects	subject	NOUN
iajs-314	64	22	in	in	ADP
iajs-314	64	23	this	this	DET
iajs-314	64	24	study	study	NOUN
iajs-314	64	25	.	.	PUNCT
iajs-314	65	1	this	this	PRON
iajs-314	65	2	reveals	reveal	VERB
iajs-314	65	3	that	that	SCONJ
iajs-314	65	4	there	there	PRON
iajs-314	65	5	is	be	VERB
iajs-314	65	6	as	as	ADP
iajs-314	65	7	association	association	NOUN
iajs-314	65	8	between	between	ADP
iajs-314	65	9	hs	hs	PROPN
iajs-314	65	10	-	-	PROPN
iajs-314	65	11	crp	crp	PROPN
iajs-314	65	12	and	and	CCONJ
iajs-314	65	13	cardiovascular	cardiovascular	ADJ
iajs-314	65	14	diseases[27	diseases[27	NOUN
iajs-314	65	15	]	]	PUNCT
iajs-314	65	16	.	.	PUNCT
iajs-314	66	1	in	in	ADP
iajs-314	66	2	conclusion	conclusion	NOUN
iajs-314	66	3	:	:	PUNCT
iajs-314	66	4	the	the	DET
iajs-314	66	5	results	result	NOUN
iajs-314	66	6	that	that	PRON
iajs-314	66	7	were	be	AUX
iajs-314	66	8	drown	drown	VERB
iajs-314	66	9	from	from	ADP
iajs-314	66	10	this	this	DET
iajs-314	66	11	research	research	NOUN
iajs-314	66	12	may	may	AUX
iajs-314	66	13	confirm	confirm	VERB
iajs-314	66	14	the	the	DET
iajs-314	66	15	relationship	relationship	NOUN
iajs-314	66	16	between	between	ADP
iajs-314	66	17	high	high	ADJ
iajs-314	66	18	levels	level	NOUN
iajs-314	66	19	of	of	ADP
iajs-314	66	20	il-35	il-35	ADP
iajs-314	66	21	and	and	CCONJ
iajs-314	66	22	hs	hs	PROPN
iajs-314	66	23	-	-	PROPN
iajs-314	66	24	crp	crp	PROPN
iajs-314	66	25	with	with	ADP
iajs-314	66	26	cardiovascular	cardiovascular	ADJ
iajs-314	66	27	diseases	disease	NOUN
iajs-314	66	28	.	.	PUNCT
iajs-314	67	1	references	reference	NOUN
iajs-314	67	2	1bucova	1bucova	NUM
iajs-314	67	3	,	,	PUNCT
iajs-314	67	4	m.	m.	NOUN
iajs-314	67	5	;	;	PUNCT
iajs-314	67	6	bernadic	bernadic	ADJ
iajs-314	67	7	m.	m.	NOUN
iajs-314	67	8	and	and	CCONJ
iajs-314	67	9	buckingham	buckingham	PROPN
iajs-314	67	10	t.	t.	PROPN
iajs-314	67	11	(	(	PUNCT
iajs-314	67	12	2008	2008	NUM
iajs-314	67	13	)	)	PUNCT
iajs-314	67	14	.	.	PUNCT
iajs-314	68	1	c	c	X
iajs-314	68	2	-	-	PUNCT
iajs-314	68	3	reactive	reactive	ADJ
iajs-314	68	4	protein	protein	NOUN
iajs-314	68	5	,	,	PUNCT
iajs-314	68	6	cytokines	cytokine	NOUN
iajs-314	68	7	and	and	CCONJ
iajs-314	68	8	inflammation	inflammation	NOUN
iajs-314	68	9	in	in	ADP
iajs-314	68	10	cardiovascular	cardiovascular	ADJ
iajs-314	68	11	disease	disease	NOUN
iajs-314	68	12	.	.	PUNCT
iajs-314	69	1	bratisl	bratisl	PROPN
iajs-314	69	2	lek	lek	PROPN
iajs-314	69	3	listy	listy	PROPN
iajs-314	69	4	.	.	PUNCT
iajs-314	70	1	109	109	NUM
iajs-314	70	2	(	(	PUNCT
iajs-314	70	3	8)	8)	NUM
iajs-314	70	4	:	:	PUNCT
iajs-314	70	5	333–340	333–340	NUM
iajs-314	70	6	.	.	PUNCT
iajs-314	71	1	2ridker	2ridker	NUM
iajs-314	71	2	,	,	PUNCT
iajs-314	71	3	pm	pm	NOUN
iajs-314	71	4	.	.	PUNCT
iajs-314	71	5	;	;	PUNCT
iajs-314	71	6	fifai	fifai	PROPN
iajs-314	71	7	n.	n.	PROPN
iajs-314	71	8	,	,	PUNCT
iajs-314	71	9	stampfer	stampfer	PROPN
iajs-314	71	10	mj	mj	PROPN
iajs-314	71	11	.	.	PUNCT
iajs-314	71	12	;	;	PUNCT
iajs-314	72	1	et	et	PROPN
iajs-314	72	2	al	al	PROPN
iajs-314	72	3	.	.	PUNCT
iajs-314	72	4	plasma	plasma	NOUN
iajs-314	72	5	concentration	concentration	NOUN
iajs-314	72	6	of	of	ADP
iajs-314	72	7	interleukin-6	interleukin-6	NUM
iajs-314	72	8	and	and	CCONJ
iajs-314	72	9	the	the	DET
iajs-314	72	10	risk	risk	NOUN
iajs-314	72	11	of	of	ADP
iajs-314	72	12	future	future	ADJ
iajs-314	72	13	myocardial	myocardial	ADJ
iajs-314	72	14	infarction	infarction	NOUN
iajs-314	72	15	among	among	ADP
iajs-314	72	16	apparently	apparently	ADV
iajs-314	72	17	healthy	healthy	ADJ
iajs-314	72	18	men.circulation	men.circulation	NOUN
iajs-314	72	19	.	.	PUNCT
iajs-314	73	1	(	(	PUNCT
iajs-314	73	2	2000	2000	NUM
iajs-314	73	3	)	)	PUNCT
iajs-314	73	4	101	101	NUM
iajs-314	73	5	:	:	PUNCT
iajs-314	73	6	1767	1767	NUM
iajs-314	73	7	–	–	PUNCT
iajs-314	73	8	1772	1772	NUM
iajs-314	73	9	.	.	PUNCT
iajs-314	74	1	3	3	X
iajs-314	74	2	-	-	PUNCT
iajs-314	74	3	vasan	vasan	ADJ
iajs-314	74	4	,	,	PUNCT
iajs-314	74	5	rs	rs	NOUN
iajs-314	74	6	.	.	PUNCT
iajs-314	74	7	;	;	PUNCT
iajs-314	75	1	sullivan	sullivan	PROPN
iajs-314	75	2	lm	lm	PROPN
iajs-314	75	3	.	.	PUNCT
iajs-314	75	4	;	;	PUNCT
iajs-314	75	5	roubenoff	roubenoff	PROPN
iajs-314	75	6	r.	r.	PROPN
iajs-314	75	7	;	;	PUNCT
iajs-314	75	8	et	et	PROPN
iajs-314	75	9	al	al	PROPN
iajs-314	75	10	.	.	PUNCT
iajs-314	76	1	(	(	PUNCT
iajs-314	76	2	2003	2003	NUM
iajs-314	76	3	)	)	PUNCT
iajs-314	76	4	.	.	PUNCT
iajs-314	77	1	inflammatory	inflammatory	ADJ
iajs-314	77	2	markers	marker	NOUN
iajs-314	77	3	and	and	CCONJ
iajs-314	77	4	risk	risk	NOUN
iajs-314	77	5	of	of	ADP
iajs-314	77	6	heart	heart	NOUN
iajs-314	77	7	496	496	NUM
iajs-314	78	1	|	|	NOUN
iajs-314	78	2	chemistry	chemistry	NOUN
iajs-314	78	3	2014	2014	NUM
iajs-314	78	4	)	)	PUNCT
iajs-314	78	5	عام	عام	ADP
iajs-314	78	6	3(العدد	3(العدد	NUM
iajs-314	78	7	27المجلد	27المجلد	NUM
iajs-314	78	8	مجلة	مجلة	VERB
iajs-314	78	9	إبن	إبن	NOUN
iajs-314	78	10	الھيثم	الھيثم	NOUN
iajs-314	78	11	للعلوم	للعلوم	NOUN
iajs-314	78	12	الصرفة	الصرفة	NOUN
iajs-314	79	1	و	و	PRON
iajs-314	79	2	التطبيقية	التطبيقية	ADJ
iajs-314	79	3	ibn	ibn	PROPN
iajs-314	79	4	al	al	PROPN
iajs-314	79	5	-	-	PUNCT
iajs-314	79	6	haitham	haitham	PROPN
iajs-314	79	7	jour	jour	X
iajs-314	79	8	.	.	PROPN
iajs-314	79	9	for	for	ADP
iajs-314	79	10	pure	pure	ADJ
iajs-314	79	11	&	&	CCONJ
iajs-314	79	12	appl	appl	PROPN
iajs-314	79	13	.	.	PUNCT
iajs-314	80	1	sci	sci	PROPN
iajs-314	80	2	.	.	PUNCT
iajs-314	80	3	vol	vol	NOUN
iajs-314	80	4	.	.	PROPN
iajs-314	81	1	27	27	NUM
iajs-314	81	2	(	(	PUNCT
iajs-314	81	3	3	3	NUM
iajs-314	81	4	)	)	PUNCT
iajs-314	81	5	2014	2014	NUM
iajs-314	81	6	failure	failure	NOUN
iajs-314	81	7	in	in	ADP
iajs-314	81	8	elderly	elderly	ADJ
iajs-314	81	9	subject	subject	NOUN
iajs-314	81	10	without	without	ADP
iajs-314	81	11	prior	prior	ADJ
iajs-314	81	12	myocardial	myocardial	ADJ
iajs-314	81	13	infarction	infarction	NOUN
iajs-314	81	14	:	:	PUNCT
iajs-314	81	15	the	the	DET
iajs-314	81	16	framingham	framingham	PROPN
iajs-314	81	17	heart	heart	PROPN
iajs-314	81	18	study	study	NOUN
iajs-314	81	19	.	.	PUNCT
iajs-314	82	1	circulation	circulation	NOUN
iajs-314	82	2	.	.	PUNCT
iajs-314	83	1	107	107	NUM
iajs-314	83	2	:	:	PUNCT
iajs-314	83	3	1486–1491	1486–1491	NUM
iajs-314	83	4	.	.	PUNCT
iajs-314	84	1	4koukkunen	4koukkunen	NUM
iajs-314	84	2	,	,	PUNCT
iajs-314	84	3	h.	h.	PROPN
iajs-314	84	4	;	;	PUNCT
iajs-314	84	5	penttila	penttila	PROPN
iajs-314	84	6	k.	k.	PROPN
iajs-314	84	7	;	;	PUNCT
iajs-314	84	8	kemppainen	kemppainen	PROPN
iajs-314	84	9	a.	a.	PROPN
iajs-314	84	10	;	;	PUNCT
iajs-314	84	11	et	et	NOUN
iajs-314	84	12	al.(2001	al.(2001	ADJ
iajs-314	84	13	)	)	PUNCT
iajs-314	84	14	c	c	NOUN
iajs-314	84	15	-	-	PUNCT
iajs-314	84	16	reactive	reactive	ADJ
iajs-314	84	17	protein	protein	NOUN
iajs-314	84	18	,	,	PUNCT
iajs-314	84	19	fibrinogen	fibrinogen	NOUN
iajs-314	84	20	,	,	PUNCT
iajs-314	84	21	interleukin-6	interleukin-6	NUM
iajs-314	84	22	and	and	CCONJ
iajs-314	84	23	tumor	tumor	NOUN
iajs-314	84	24	necrosis	necrosis	NOUN
iajs-314	84	25	factor	factor	NOUN
iajs-314	84	26	-	-	PUNCT
iajs-314	84	27	alpha	alpha	NOUN
iajs-314	84	28	in	in	ADP
iajs-314	84	29	the	the	DET
iajs-314	84	30	classification	classification	NOUN
iajs-314	84	31	of	of	ADP
iajs-314	84	32	unstable	unstable	ADJ
iajs-314	84	33	angina	angina	NOUN
iajs-314	84	34	pectoris	pectoris	PROPN
iajs-314	84	35	.	.	PUNCT
iajs-314	85	1	ann	ann	PROPN
iajs-314	85	2	med	med	PROPN
iajs-314	85	3	.	.	PUNCT
iajs-314	86	1	33	33	NUM
iajs-314	86	2	:	:	PUNCT
iajs-314	86	3	37	37	NUM
iajs-314	86	4	-	-	SYM
iajs-314	86	5	47	47	NUM
iajs-314	86	6	.	.	PUNCT
iajs-314	87	1	5lin	5lin	NUM
iajs-314	87	2	,	,	PUNCT
iajs-314	87	3	y.	y.	PROPN
iajs-314	87	4	;	;	PUNCT
iajs-314	87	5	huang	huang	PROPN
iajs-314	87	6	y.	y.	PROPN
iajs-314	87	7	;	;	PUNCT
iajs-314	87	8	lu	lu	PROPN
iajs-314	87	9	z.	z.	PROPN
iajs-314	87	10	;	;	PUNCT
iajs-314	87	11	luo	luo	PROPN
iajs-314	87	12	c.	c.	PROPN
iajs-314	87	13	;	;	PUNCT
iajs-314	87	14	shi	shi	PROPN
iajs-314	87	15	y.	y.	PROPN
iajs-314	87	16	;	;	PUNCT
iajs-314	87	17	et	et	PROPN
iajs-314	87	18	al	al	PROPN
iajs-314	87	19	.	.	PUNCT
iajs-314	87	20	(	(	PUNCT
iajs-314	87	21	2012	2012	NUM
iajs-314	87	22	)	)	PUNCT
iajs-314	87	23	.	.	PUNCT
iajs-314	88	1	decreased	decrease	VERB
iajs-314	88	2	plasma	plasma	NOUN
iajs-314	88	3	il-35	il-35	ADP
iajs-314	88	4	levels	level	NOUN
iajs-314	88	5	are	be	AUX
iajs-314	88	6	related	relate	VERB
iajs-314	88	7	to	to	ADP
iajs-314	88	8	the	the	DET
iajs-314	88	9	left	left	ADJ
iajs-314	88	10	ventricular	ventricular	ADJ
iajs-314	88	11	ejection	ejection	NOUN
iajs-314	88	12	fraction	fraction	NOUN
iajs-314	88	13	in	in	ADP
iajs-314	88	14	coronary	coronary	ADJ
iajs-314	88	15	artery	artery	NOUN
iajs-314	88	16	diseases	disease	NOUN
iajs-314	88	17	.	.	PUNCT
iajs-314	89	1	plos	plos	PROPN
iajs-314	89	2	one	one	NUM
iajs-314	89	3	7	7	NUM
iajs-314	89	4	:	:	PUNCT
iajs-314	89	5	e52490	e52490	NOUN
iajs-314	89	6	.	.	PUNCT
iajs-314	90	1	6niedbala	6niedbala	NUM
iajs-314	90	2	,	,	PUNCT
iajs-314	90	3	w.	w.	PROPN
iajs-314	90	4	;	;	PUNCT
iajs-314	90	5	wei	wei	PROPN
iajs-314	90	6	xq	xq	PROPN
iajs-314	90	7	.	.	PROPN
iajs-314	90	8	,	,	PUNCT
iajs-314	90	9	cai	cai	PROPN
iajs-314	91	1	b	b	X
iajs-314	91	2	;	;	PUNCT
iajs-314	91	3	hueber	hueber	PROPN
iajs-314	91	4	aj	aj	PROPN
iajs-314	91	5	.	.	PROPN
iajs-314	91	6	;	;	PUNCT
iajs-314	91	7	leung	leung	PROPN
iajs-314	91	8	bp	bp	PROPN
iajs-314	91	9	.	.	PROPN
iajs-314	91	10	;	;	PUNCT
iajs-314	91	11	et	et	NOUN
iajs-314	91	12	al.(2006	al.(2006	PROPN
iajs-314	91	13	)	)	PUNCT
iajs-314	91	14	.	.	PUNCT
iajs-314	92	1	il-35	il-35	PROPN
iajs-314	92	2	is	be	AUX
iajs-314	92	3	a	a	DET
iajs-314	92	4	novel	novel	ADJ
iajs-314	92	5	cytokine	cytokine	NOUN
iajs-314	92	6	with	with	ADP
iajs-314	92	7	therapeutic	therapeutic	ADJ
iajs-314	92	8	effects	effect	NOUN
iajs-314	92	9	against	against	ADP
iajs-314	92	10	collagen	collagen	NOUN
iajs-314	92	11	-	-	PUNCT
iajs-314	92	12	induced	induce	VERB
iajs-314	92	13	arthritis	arthritis	NOUN
iajs-314	92	14	through	through	ADP
iajs-314	92	15	the	the	DET
iajs-314	92	16	expansion	expansion	NOUN
iajs-314	92	17	of	of	ADP
iajs-314	92	18	regulatory	regulatory	ADJ
iajs-314	92	19	t	t	NOUN
iajs-314	92	20	cells	cell	NOUN
iajs-314	92	21	and	and	CCONJ
iajs-314	92	22	suppression	suppression	NOUN
iajs-314	92	23	of	of	ADP
iajs-314	92	24	th17	th17	NOUN
iajs-314	92	25	cells	cell	NOUN
iajs-314	92	26	.	.	PUNCT
iajs-314	93	1	eur	eur	PROPN
iajs-314	93	2	j	j	PROPN
iajs-314	93	3	immunol	immunol	NOUN
iajs-314	93	4	37	37	NUM
iajs-314	93	5	:	:	PUNCT
iajs-314	93	6	3021–3029	3021–3029	NUM
iajs-314	93	7	.	.	PUNCT
iajs-314	94	1	7collison	7collison	NUM
iajs-314	94	2	,	,	PUNCT
iajs-314	94	3	lw	lw	PROPN
iajs-314	94	4	.	.	PUNCT
iajs-314	94	5	;	;	PUNCT
iajs-314	94	6	workman	workman	NOUN
iajs-314	94	7	cj	cj	PROPN
iajs-314	94	8	.	.	PUNCT
iajs-314	94	9	;	;	PUNCT
iajs-314	94	10	kuo	kuo	PROPN
iajs-314	94	11	tt	tt	PROPN
iajs-314	94	12	.	.	PROPN
iajs-314	94	13	;	;	PUNCT
iajs-314	94	14	boyd	boyd	PROPN
iajs-314	94	15	k.	k.	PROPN
iajs-314	94	16	;	;	PUNCT
iajs-314	94	17	wang	wang	PROPN
iajs-314	94	18	y.	y.	PROPN
iajs-314	94	19	;	;	PUNCT
iajs-314	94	20	vignali	vignali	PROPN
iajs-314	94	21	,	,	PUNCT
iajs-314	94	22	k.m	k.m	PROPN
iajs-314	94	23	.	.	PROPN
iajs-314	94	24	;	;	PUNCT
iajs-314	94	25	cross	cross	PROPN
iajs-314	94	26	,	,	PUNCT
iajs-314	94	27	r.	r.	PROPN
iajs-314	94	28	;	;	PUNCT
iajs-314	94	29	sehy	sehy	NOUN
iajs-314	94	30	,	,	PUNCT
iajs-314	94	31	d.	d.	PROPN
iajs-314	94	32	;	;	PUNCT
iajs-314	95	1	blumberg	blumberg	PROPN
iajs-314	95	2	,	,	PUNCT
iajs-314	95	3	r.s	r.s	PROPN
iajs-314	95	4	.	.	PROPN
iajs-314	95	5	;	;	PUNCT
iajs-314	95	6	and	and	CCONJ
iajs-314	95	7	vignali	vignali	VERB
iajs-314	95	8	,	,	PUNCT
iajs-314	95	9	d.a.(2007	d.a.(2007	PROPN
iajs-314	95	10	)	)	PUNCT
iajs-314	95	11	.	.	PUNCT
iajs-314	96	1	the	the	DET
iajs-314	96	2	inhibitory	inhibitory	ADJ
iajs-314	96	3	cytokine	cytokine	NOUN
iajs-314	96	4	il-35	il-35	ADP
iajs-314	96	5	contributes	contribute	VERB
iajs-314	96	6	to	to	ADP
iajs-314	96	7	regulatory	regulatory	ADJ
iajs-314	96	8	t	t	PROPN
iajs-314	96	9	-	-	PUNCT
iajs-314	96	10	cell	cell	NOUN
iajs-314	96	11	function	function	NOUN
iajs-314	96	12	.	.	PUNCT
iajs-314	97	1	nature	nature	NOUN
iajs-314	97	2	450	450	NUM
iajs-314	97	3	:	:	PUNCT
iajs-314	97	4	566–569	566–569	NUM
iajs-314	97	5	.	.	PUNCT
iajs-314	98	1	8collison	8collison	NUM
iajs-314	98	2	,	,	PUNCT
iajs-314	98	3	lw	lw	NOUN
iajs-314	98	4	.	.	PUNCT
iajs-314	99	1	and	and	CCONJ
iajs-314	99	2	vignali	vignali	PROPN
iajs-314	99	3	da	da	PROPN
iajs-314	99	4	.	.	PUNCT
iajs-314	100	1	(	(	PUNCT
iajs-314	100	2	2008	2008	NUM
iajs-314	100	3	)	)	PUNCT
iajs-314	100	4	.	.	PUNCT
iajs-314	101	1	interleukin-35	interleukin-35	PROPN
iajs-314	101	2	:	:	PUNCT
iajs-314	101	3	odd	odd	ADJ
iajs-314	101	4	one	one	NUM
iajs-314	101	5	out	out	ADP
iajs-314	101	6	or	or	CCONJ
iajs-314	101	7	part	part	NOUN
iajs-314	101	8	of	of	ADP
iajs-314	101	9	the	the	DET
iajs-314	101	10	family	family	NOUN
iajs-314	101	11	?	?	PUNCT
iajs-314	101	12	.	.	PUNCT
iajs-314	102	1	immunol	immunol	NOUN
iajs-314	102	2	rev	rev	VERB
iajs-314	102	3	226	226	NUM
iajs-314	102	4	:	:	PUNCT
iajs-314	102	5	248–262	248–262	NUM
iajs-314	102	6	.	.	PUNCT
iajs-314	103	1	9devergne	9devergne	NUM
iajs-314	103	2	,	,	PUNCT
iajs-314	103	3	o.	o.	PROPN
iajs-314	103	4	;	;	PUNCT
iajs-314	103	5	hummel	hummel	PROPN
iajs-314	103	6	,	,	PUNCT
iajs-314	103	7	m.	m.	NOUN
iajs-314	103	8	;	;	PUNCT
iajs-314	103	9	koeppen	koeppen	PROPN
iajs-314	103	10	,	,	PUNCT
iajs-314	103	11	h.	h.	PROPN
iajs-314	103	12	;	;	PUNCT
iajs-314	103	13	le	le	X
iajs-314	103	14	beau	beau	PROPN
iajs-314	103	15	,	,	PUNCT
iajs-314	103	16	m.	m.	NOUN
iajs-314	103	17	m.	m.	NOUN
iajs-314	103	18	;	;	PUNCT
iajs-314	103	19	nathanson	nathanson	PROPN
iajs-314	103	20	,	,	PUNCT
iajs-314	103	21	e.	e.	PROPN
iajs-314	103	22	c.	c.	PROPN
iajs-314	103	23	;	;	PUNCT
iajs-314	103	24	kieff	kieff	PROPN
iajs-314	103	25	,	,	PUNCT
iajs-314	103	26	e.	e.	PROPN
iajs-314	103	27	and	and	CCONJ
iajs-314	103	28	birkenbach	birkenbach	PROPN
iajs-314	103	29	,	,	PUNCT
iajs-314	103	30	m.	m.	NOUN
iajs-314	103	31	(	(	PUNCT
iajs-314	103	32	1996	1996	NUM
iajs-314	103	33	)	)	PUNCT
iajs-314	103	34	.	.	PUNCT
iajs-314	104	1	a	a	DET
iajs-314	104	2	novel	novel	ADJ
iajs-314	104	3	interleukin-12	interleukin-12	NOUN
iajs-314	104	4	p40	p40	NOUN
iajs-314	104	5	-	-	PUNCT
iajs-314	104	6	related	relate	VERB
iajs-314	104	7	protein	protein	NOUN
iajs-314	104	8	induced	induce	VERB
iajs-314	104	9	by	by	ADP
iajs-314	104	10	latent	latent	NOUN
iajs-314	104	11	epsteinbarr	epsteinbarr	PROPN
iajs-314	104	12	virus	virus	NOUN
iajs-314	104	13	infection	infection	NOUN
iajs-314	104	14	in	in	ADP
iajs-314	104	15	b	b	NOUN
iajs-314	104	16	lymphocytes	lymphocyte	NOUN
iajs-314	104	17	.	.	PUNCT
iajs-314	105	1	j.	j.	PROPN
iajs-314	105	2	virol	virol	PROPN
iajs-314	105	3	.	.	PUNCT
iajs-314	106	1	70	70	NUM
iajs-314	106	2	:	:	PUNCT
iajs-314	106	3	1143–1153	1143–1153	NUM
iajs-314	106	4	.	.	PUNCT
iajs-314	107	1	10collison	10collison	NUM
iajs-314	107	2	,	,	PUNCT
iajs-314	107	3	lw	lw	PROPN
iajs-314	107	4	.	.	PUNCT
iajs-314	107	5	;	;	PUNCT
iajs-314	108	1	pillai	pillai	PROPN
iajs-314	108	2	mr	mr	PROPN
iajs-314	108	3	.	.	PROPN
iajs-314	108	4	;	;	PUNCT
iajs-314	108	5	chaturvedi	chaturvedi	PROPN
iajs-314	108	6	v.	v.	PROPN
iajs-314	108	7	and	and	CCONJ
iajs-314	108	8	vignali	vignali	PROPN
iajs-314	108	9	da	da	PROPN
iajs-314	108	10	.	.	PUNCT
iajs-314	109	1	(	(	PUNCT
iajs-314	109	2	2009	2009	NUM
iajs-314	109	3	)	)	PUNCT
iajs-314	109	4	.	.	PUNCT
iajs-314	110	1	regulatory	regulatory	ADJ
iajs-314	110	2	t	t	PROPN
iajs-314	110	3	cell	cell	NOUN
iajs-314	110	4	suppression	suppression	NOUN
iajs-314	110	5	is	be	AUX
iajs-314	110	6	potentiated	potentiate	VERB
iajs-314	110	7	by	by	ADP
iajs-314	110	8	target	target	NOUN
iajs-314	110	9	t	t	NOUN
iajs-314	110	10	cells	cell	NOUN
iajs-314	110	11	in	in	ADP
iajs-314	110	12	a	a	DET
iajs-314	110	13	cell	cell	NOUN
iajs-314	110	14	contact	contact	NOUN
iajs-314	110	15	,	,	PUNCT
iajs-314	110	16	il-35and	il-35and	NOUN
iajs-314	110	17	il-10	il-10	X
iajs-314	110	18	dependent	dependent	ADJ
iajs-314	110	19	manner	manner	NOUN
iajs-314	110	20	,	,	PUNCT
iajs-314	110	21	j.	j.	PROPN
iajs-314	110	22	immunol	immunol	PROPN
iajs-314	110	23	.	.	PUNCT
iajs-314	111	1	182	182	NUM
iajs-314	111	2	:	:	PUNCT
iajs-314	111	3	6121–6128	6121–6128	NUM
iajs-314	111	4	.	.	PUNCT
iajs-314	112	1	11huang	11huang	NUM
iajs-314	112	2	,	,	PUNCT
iajs-314	112	3	ch	ch	NOUN
iajs-314	112	4	.	.	PUNCT
iajs-314	112	5	;	;	PUNCT
iajs-314	112	6	loo	loo	VERB
iajs-314	112	7	ex	ex	PROPN
iajs-314	112	8	.	.	PROPN
iajs-314	112	9	;	;	PUNCT
iajs-314	112	10	kuo	kuo	PROPN
iajs-314	112	11	ic	ic	PROPN
iajs-314	112	12	.	.	PROPN
iajs-314	112	13	;	;	PUNCT
iajs-314	113	1	soh	soh	PROPN
iajs-314	113	2	gh	gh	PROPN
iajs-314	113	3	.	.	PROPN
iajs-314	113	4	;	;	PUNCT
iajs-314	113	5	goh	goh	PROPN
iajs-314	113	6	dl	dl	PROPN
iajs-314	113	7	.	.	PROPN
iajs-314	113	8	;	;	PUNCT
iajs-314	113	9	et	et	PROPN
iajs-314	113	10	al	al	PROPN
iajs-314	113	11	.	.	PUNCT
iajs-314	114	1	(	(	PUNCT
iajs-314	114	2	2011	2011	NUM
iajs-314	114	3	)	)	PUNCT
iajs-314	114	4	.	.	PUNCT
iajs-314	115	1	airway	airway	NOUN
iajs-314	115	2	inflammation	inflammation	NOUN
iajs-314	115	3	and	and	CCONJ
iajs-314	115	4	ige	ige	PROPN
iajs-314	115	5	production	production	NOUN
iajs-314	115	6	induced	induce	VERB
iajs-314	115	7	by	by	ADP
iajs-314	115	8	dust	dust	NOUN
iajs-314	115	9	mite	mite	PROPN
iajs-314	115	10	allergen	allergen	NOUN
iajs-314	115	11	-	-	PUNCT
iajs-314	115	12	specific	specific	ADJ
iajs-314	115	13	memory	memory	NOUN
iajs-314	115	14	/	/	SYM
iajs-314	115	15	effector	effector	NOUN
iajs-314	115	16	th2	th2	PROPN
iajs-314	115	17	cell	cell	NOUN
iajs-314	115	18	line	line	NOUN
iajs-314	115	19	can	can	AUX
iajs-314	115	20	be	be	AUX
iajs-314	115	21	effectively	effectively	ADV
iajs-314	115	22	attenuated	attenuate	VERB
iajs-314	115	23	by	by	ADP
iajs-314	115	24	il-35	il-35	PRON
iajs-314	115	25	.	.	PUNCT
iajs-314	116	1	j	j	PROPN
iajs-314	116	2	immunol	immunol	NOUN
iajs-314	116	3	187	187	NUM
iajs-314	116	4	:	:	PUNCT
iajs-314	116	5	462–471	462–471	NUM
iajs-314	116	6	.	.	PUNCT
iajs-314	117	1	12wirtz	12wirtz	NUM
iajs-314	117	2	,	,	PUNCT
iajs-314	117	3	s.	s.	PROPN
iajs-314	117	4	;	;	PUNCT
iajs-314	117	5	billmeier	billmeier	PROPN
iajs-314	117	6	u.	u.	PROPN
iajs-314	117	7	;	;	PUNCT
iajs-314	117	8	mchedlidze	mchedlidze	PROPN
iajs-314	117	9	t.	t.	PROPN
iajs-314	117	10	;	;	PUNCT
iajs-314	117	11	blumberg	blumberg	PROPN
iajs-314	117	12	rs	rs	PROPN
iajs-314	117	13	.	.	PUNCT
iajs-314	118	1	and	and	CCONJ
iajs-314	118	2	neurath	neurath	PROPN
iajs-314	118	3	mf	mf	PROPN
iajs-314	118	4	.	.	PUNCT
iajs-314	119	1	(	(	PUNCT
iajs-314	119	2	2011	2011	NUM
iajs-314	119	3	)	)	PUNCT
iajs-314	119	4	.	.	PUNCT
iajs-314	120	1	interleukin-35	interleukin-35	NOUN
iajs-314	120	2	mediates	mediate	NOUN
iajs-314	120	3	mucosal	mucosal	ADJ
iajs-314	120	4	immune	immune	ADJ
iajs-314	120	5	responses	response	NOUN
iajs-314	120	6	that	that	PRON
iajs-314	120	7	protect	protect	VERB
iajs-314	120	8	against	against	ADP
iajs-314	120	9	t	t	NOUN
iajs-314	120	10	-	-	PUNCT
iajs-314	120	11	cell	cell	NOUN
iajs-314	120	12	dependent	dependent	ADJ
iajs-314	120	13	colitis	colitis	NOUN
iajs-314	120	14	.	.	PUNCT
iajs-314	121	1	gastroenterology	gastroenterology	NOUN
iajs-314	121	2	141	141	NUM
iajs-314	121	3	:	:	SYM
iajs-314	121	4	1875–1886	1875–1886	NUM
iajs-314	121	5	.	.	PUNCT
iajs-314	122	1	13whitehead	13whitehead	NUM
iajs-314	122	2	,	,	PUNCT
iajs-314	122	3	gs	gs	PROPN
iajs-314	122	4	.	.	PUNCT
iajs-314	122	5	;	;	PUNCT
iajs-314	122	6	wilson	wilson	PROPN
iajs-314	122	7	rh	rh	PROPN
iajs-314	122	8	.	.	PROPN
iajs-314	122	9	;	;	PUNCT
iajs-314	122	10	nakano	nakano	PROPN
iajs-314	122	11	k	k	PROPN
iajs-314	122	12	;	;	PUNCT
iajs-314	122	13	burch	burch	PROPN
iajs-314	122	14	lh	lh	PROPN
iajs-314	122	15	.	.	PROPN
iajs-314	122	16	;	;	PUNCT
iajs-314	122	17	nakano	nakano	PROPN
iajs-314	122	18	h.	h.	PROPN
iajs-314	122	19	;	;	PUNCT
iajs-314	122	20	et	et	NOUN
iajs-314	122	21	al.(2012	al.(2012	NOUN
iajs-314	122	22	)	)	PUNCT
iajs-314	122	23	.	.	PUNCT
iajs-314	123	1	il-35	il-35	ADP
iajs-314	123	2	production	production	NOUN
iajs-314	123	3	by	by	ADP
iajs-314	123	4	inducible	inducible	ADJ
iajs-314	123	5	costimulator	costimulator	NOUN
iajs-314	123	6	(	(	PUNCT
iajs-314	123	7	icos)-positive	icos)-positive	PROPN
iajs-314	123	8	regulatory	regulatory	ADJ
iajs-314	123	9	t	t	NOUN
iajs-314	123	10	cells	cell	NOUN
iajs-314	123	11	reverses	reverse	VERB
iajs-314	123	12	established	establish	VERB
iajs-314	123	13	il-17	il-17	ADV
iajs-314	123	14	-	-	PUNCT
iajs-314	123	15	dependent	dependent	ADJ
iajs-314	123	16	allergic	allergic	ADJ
iajs-314	123	17	airways	airway	NOUN
iajs-314	123	18	disease	disease	NOUN
iajs-314	123	19	.	.	PUNCT
iajs-314	124	1	j	j	PROPN
iajs-314	124	2	allergy	allergy	PROPN
iajs-314	124	3	clin	clin	PROPN
iajs-314	124	4	.	.	PUNCT
iajs-314	125	1	immunol	immunol	NOUN
iajs-314	125	2	129	129	NUM
iajs-314	125	3	:	:	PUNCT
iajs-314	125	4	207–215	207–215	NUM
iajs-314	125	5	.	.	PUNCT
iajs-314	126	1	14kempe	14kempe	NUM
iajs-314	126	2	,	,	PUNCT
iajs-314	126	3	s.	s.	PROPN
iajs-314	126	4	;	;	PUNCT
iajs-314	126	5	kestler	kestler	PROPN
iajs-314	126	6	h.	h.	PROPN
iajs-314	126	7	;	;	PUNCT
iajs-314	126	8	lasar	lasar	PROPN
iajs-314	126	9	a.	a.	NOUN
iajs-314	126	10	and	and	CCONJ
iajs-314	126	11	wirth	wirth	PROPN
iajs-314	126	12	t.	t.	PROPN
iajs-314	126	13	(	(	PUNCT
iajs-314	126	14	2005	2005	NUM
iajs-314	126	15	)	)	PUNCT
iajs-314	126	16	.	.	PUNCT
iajs-314	127	1	nf	nf	X
iajs-314	127	2	-	-	PUNCT
iajs-314	127	3	kappab	kappab	NOUN
iajs-314	127	4	controls	control	VERB
iajs-314	127	5	the	the	DET
iajs-314	127	6	global	global	ADJ
iajs-314	127	7	pro	pro	ADJ
iajs-314	127	8	inflammatory	inflammatory	ADJ
iajs-314	127	9	response	response	NOUN
iajs-314	127	10	in	in	ADP
iajs-314	127	11	endothelial	endothelial	ADJ
iajs-314	127	12	cells	cell	NOUN
iajs-314	127	13	:	:	PUNCT
iajs-314	127	14	evidence	evidence	NOUN
iajs-314	127	15	for	for	ADP
iajs-314	127	16	the	the	DET
iajs-314	127	17	regulation	regulation	NOUN
iajs-314	127	18	of	of	ADP
iajs-314	127	19	a	a	DET
iajs-314	127	20	pro	pro	ADJ
iajs-314	127	21	therogenic	therogenic	ADJ
iajs-314	127	22	program	program	NOUN
iajs-314	127	23	.	.	PUNCT
iajs-314	128	1	nucleic	nucleic	ADJ
iajs-314	128	2	acids	acid	NOUN
iajs-314	128	3	res	re	NOUN
iajs-314	128	4	33:5308–5319	33:5308–5319	PROPN
iajs-314	128	5	.	.	PUNCT
iajs-314	129	1	15chaturvedi	15chaturvedi	NUM
iajs-314	130	1	v.	v.	ADV
iajs-314	130	2	;	;	PUNCT
iajs-314	130	3	collison	collison	PROPN
iajs-314	130	4	lw	lw	PROPN
iajs-314	130	5	.	.	PROPN
iajs-314	130	6	;	;	PUNCT
iajs-314	130	7	guy	guy	NOUN
iajs-314	130	8	cs	cs	PROPN
iajs-314	130	9	.	.	PROPN
iajs-314	130	10	;	;	PUNCT
iajs-314	130	11	workman	workman	NOUN
iajs-314	130	12	cj	cj	PROPN
iajs-314	130	13	.	.	PUNCT
iajs-314	131	1	and	and	CCONJ
iajs-314	131	2	vignali	vignali	ADJ
iajs-314	131	3	da.(2011	da.(2011	NOUN
iajs-314	131	4	)	)	PUNCT
iajs-314	131	5	.	.	PUNCT
iajs-314	132	1	cutting	cut	VERB
iajs-314	132	2	edge	edge	NOUN
iajs-314	132	3	:	:	PUNCT
iajs-314	132	4	human	human	ADJ
iajs-314	132	5	regulatory	regulatory	ADJ
iajs-314	132	6	t	t	PROPN
iajs-314	132	7	cells	cell	NOUN
iajs-314	132	8	require	require	VERB
iajs-314	132	9	il-35	il-35	ADP
iajs-314	132	10	to	to	PART
iajs-314	132	11	mediate	mediate	VERB
iajs-314	132	12	suppression	suppression	NOUN
iajs-314	132	13	and	and	CCONJ
iajs-314	132	14	infectious	infectious	ADJ
iajs-314	132	15	tolerance	tolerance	NOUN
iajs-314	132	16	.	.	PUNCT
iajs-314	133	1	j	j	PROPN
iajs-314	133	2	immunol	immunol	NOUN
iajs-314	133	3	186	186	NUM
iajs-314	133	4	:	:	PUNCT
iajs-314	133	5	6661–6666	6661–6666	NUM
iajs-314	133	6	.	.	PUNCT
iajs-314	134	1	16collison	16collison	NUM
iajs-314	134	2	,	,	PUNCT
iajs-314	134	3	lw	lw	PROPN
iajs-314	134	4	.	.	PUNCT
iajs-314	134	5	;	;	PUNCT
iajs-314	135	1	chaturvedi	chaturvedi	PROPN
iajs-314	135	2	v.	v.	PROPN
iajs-314	135	3	;	;	PUNCT
iajs-314	135	4	henderson	henderson	PROPN
iajs-314	135	5	al	al	PROPN
iajs-314	135	6	.	.	PROPN
iajs-314	135	7	;	;	PUNCT
iajs-314	135	8	giacomin	giacomin	VERB
iajs-314	135	9	pr	pr	NOUN
iajs-314	135	10	.	.	PUNCT
iajs-314	135	11	;	;	PUNCT
iajs-314	135	12	guy	guy	PROPN
iajs-314	135	13	c.	c.	PROPN
iajs-314	135	14	;	;	PUNCT
iajs-314	135	15	et	et	NOUN
iajs-314	135	16	al.(2010	al.(2010	NOUN
iajs-314	135	17	)	)	PUNCT
iajs-314	135	18	.	.	PUNCT
iajs-314	136	1	il35mediated	il35mediate	VERB
iajs-314	136	2	induction	induction	NOUN
iajs-314	136	3	of	of	ADP
iajs-314	136	4	a	a	DET
iajs-314	136	5	potent	potent	ADJ
iajs-314	136	6	regulatory	regulatory	ADJ
iajs-314	136	7	t	t	NOUN
iajs-314	136	8	cell	cell	NOUN
iajs-314	136	9	population	population	NOUN
iajs-314	136	10	.	.	PUNCT
iajs-314	137	1	nat	nat	PROPN
iajs-314	137	2	.	.	PUNCT
iajs-314	138	1	immunol	immunol	NOUN
iajs-314	138	2	11	11	NUM
iajs-314	138	3	:	:	SYM
iajs-314	138	4	1093	1093	NUM
iajs-314	138	5	–	–	PUNCT
iajs-314	138	6	1101	1101	NUM
iajs-314	138	7	.	.	PUNCT
iajs-314	139	1	17kochetkova	17kochetkova	NUM
iajs-314	139	2	,	,	PUNCT
iajs-314	139	3	i.	i.	NOUN
iajs-314	139	4	;	;	PUNCT
iajs-314	139	5	golden	golden	PROPN
iajs-314	139	6	s.	s.	PROPN
iajs-314	139	7	;	;	PUNCT
iajs-314	139	8	holderness	holderness	PROPN
iajs-314	139	9	k.	k.	PROPN
iajs-314	139	10	;	;	PUNCT
iajs-314	139	11	callis	callis	PROPN
iajs-314	139	12	g.	g.	PROPN
iajs-314	139	13	and	and	CCONJ
iajs-314	139	14	pascual	pascual	PROPN
iajs-314	139	15	dw.(2010	dw.(2010	PROPN
iajs-314	139	16	)	)	PUNCT
iajs-314	139	17	.	.	PUNCT
iajs-314	140	1	il-35	il-35	ADP
iajs-314	140	2	stimulation	stimulation	NOUN
iajs-314	140	3	of	of	ADP
iajs-314	140	4	cd39	cd39	PROPN
iajs-314	140	5	+	+	SYM
iajs-314	140	6	regulatory	regulatory	ADJ
iajs-314	140	7	t	t	NOUN
iajs-314	140	8	cells	cell	NOUN
iajs-314	140	9	confers	confer	VERB
iajs-314	140	10	protection	protection	NOUN
iajs-314	140	11	against	against	ADP
iajs-314	140	12	collagen	collagen	NOUN
iajs-314	140	13	iiinduced	iiinduce	VERB
iajs-314	140	14	arthritis	arthritis	NOUN
iajs-314	140	15	via	via	ADP
iajs-314	140	16	the	the	DET
iajs-314	140	17	production	production	NOUN
iajs-314	140	18	of	of	ADP
iajs-314	140	19	il-10	il-10	PRON
iajs-314	140	20	.	.	PUNCT
iajs-314	141	1	j	j	PROPN
iajs-314	141	2	immunol	immunol	NOUN
iajs-314	141	3	184	184	NUM
iajs-314	141	4	:	:	SYM
iajs-314	141	5	7144	7144	NUM
iajs-314	141	6	–	–	PUNCT
iajs-314	141	7	7153	7153	NUM
iajs-314	141	8	.	.	PUNCT
iajs-314	142	1	497	497	NUM
iajs-314	142	2	|	|	ADV
iajs-314	142	3	chemistry	chemistry	NOUN
iajs-314	142	4	2014	2014	NUM
iajs-314	142	5	)	)	PUNCT
iajs-314	142	6	عام	عام	ADP
iajs-314	142	7	3(العدد	3(العدد	NUM
iajs-314	142	8	27المجلد	27المجلد	NUM
iajs-314	142	9	مجلة	مجلة	VERB
iajs-314	142	10	إبن	إبن	NOUN
iajs-314	142	11	الھيثم	الھيثم	NOUN
iajs-314	142	12	للعلوم	للعلوم	NOUN
iajs-314	142	13	الصرفة	الصرفة	NOUN
iajs-314	143	1	و	و	PRON
iajs-314	143	2	التطبيقية	التطبيقية	ADJ
iajs-314	143	3	ibn	ibn	PROPN
iajs-314	143	4	al	al	PROPN
iajs-314	143	5	-	-	PUNCT
iajs-314	143	6	haitham	haitham	PROPN
iajs-314	143	7	jour	jour	X
iajs-314	143	8	.	.	PROPN
iajs-314	143	9	for	for	ADP
iajs-314	143	10	pure	pure	ADJ
iajs-314	143	11	&	&	CCONJ
iajs-314	143	12	appl	appl	PROPN
iajs-314	143	13	.	.	PUNCT
iajs-314	144	1	sci	sci	PROPN
iajs-314	144	2	.	.	PUNCT
iajs-314	144	3	vol	vol	NOUN
iajs-314	144	4	.	.	PROPN
iajs-314	145	1	27	27	NUM
iajs-314	145	2	(	(	PUNCT
iajs-314	145	3	3	3	NUM
iajs-314	145	4	)	)	PUNCT
iajs-314	145	5	2014	2014	NUM
iajs-314	145	6	18daniel	18daniel	NUM
iajs-314	145	7	,	,	PUNCT
iajs-314	145	8	g.	g.	PROPN
iajs-314	145	9	;	;	PUNCT
iajs-314	145	10	hackam	hackam	PROPN
iajs-314	145	11	sonia	sonia	PROPN
iajs-314	145	12	s.	s.	PROPN
iajs-314	145	13	and	and	CCONJ
iajs-314	145	14	anand	anand	PROPN
iajs-314	145	15	.	.	PUNCT
iajs-314	146	1	(	(	PUNCT
iajs-314	146	2	2003	2003	NUM
iajs-314	146	3	)	)	PUNCT
iajs-314	146	4	.	.	PUNCT
iajs-314	147	1	emerging	emerge	VERB
iajs-314	147	2	risk	risk	NOUN
iajs-314	147	3	factors	factor	NOUN
iajs-314	147	4	for	for	ADP
iajs-314	147	5	atherosclerotic	atherosclerotic	ADJ
iajs-314	147	6	disease	disease	NOUN
iajs-314	147	7	:	:	PUNCT
iajs-314	147	8	a	a	DET
iajs-314	147	9	critical	critical	ADJ
iajs-314	147	10	review	review	NOUN
iajs-314	147	11	of	of	ADP
iajs-314	147	12	the	the	DET
iajs-314	147	13	evidence	evidence	NOUN
iajs-314	147	14	.	.	PUNCT
iajs-314	148	1	journal	journal	NOUN
iajs-314	148	2	of	of	ADP
iajs-314	148	3	american	american	PROPN
iajs-314	148	4	heart	heart	PROPN
iajs-314	148	5	association	association	PROPN
iajs-314	148	6	290	290	NUM
iajs-314	148	7	:	:	PUNCT
iajs-314	148	8	932	932	NUM
iajs-314	148	9	940	940	NUM
iajs-314	148	10	.	.	PUNCT
iajs-314	149	1	19osmand	19osmand	NUM
iajs-314	149	2	,	,	PUNCT
iajs-314	149	3	ap	ap	PROPN
iajs-314	149	4	.	.	PUNCT
iajs-314	149	5	;	;	PUNCT
iajs-314	149	6	friedenson	friedenson	PROPN
iajs-314	149	7	b.	b.	PROPN
iajs-314	149	8	;	;	PUNCT
iajs-314	149	9	gewurz	gewurz	PROPN
iajs-314	149	10	h.	h.	PROPN
iajs-314	149	11	;	;	PUNCT
iajs-314	149	12	painter	painter	PROPN
iajs-314	149	13	rh	rh	PROPN
iajs-314	149	14	.	.	PROPN
iajs-314	149	15	;	;	PUNCT
iajs-314	149	16	hofmann	hofmann	PROPN
iajs-314	149	17	t.	t.	PROPN
iajs-314	149	18	and	and	CCONJ
iajs-314	149	19	shelton	shelton	PROPN
iajs-314	149	20	e.	e.	PROPN
iajs-314	149	21	(	(	PUNCT
iajs-314	149	22	1977	1977	NUM
iajs-314	149	23	)	)	PUNCT
iajs-314	149	24	.	.	PUNCT
iajs-314	150	1	characterisation	characterisation	NOUN
iajs-314	150	2	of	of	ADP
iajs-314	150	3	c	c	NOUN
iajs-314	150	4	-	-	PUNCT
iajs-314	150	5	reactive	reactive	ADJ
iajs-314	150	6	protein	protein	NOUN
iajs-314	150	7	and	and	CCONJ
iajs-314	150	8	the	the	DET
iajs-314	150	9	complement	complement	NOUN
iajs-314	150	10	subcomponent	subcomponent	NOUN
iajs-314	150	11	clt	clt	NOUN
iajs-314	150	12	as	as	ADP
iajs-314	150	13	homologous	homologous	ADJ
iajs-314	150	14	proteins	protein	NOUN
iajs-314	150	15	displaying	display	VERB
iajs-314	150	16	cyclic	cyclic	ADJ
iajs-314	150	17	pentameric	pentameric	NOUN
iajs-314	150	18	symmetry	symmetry	NOUN
iajs-314	150	19	(	(	PUNCT
iajs-314	150	20	pentraxins	pentraxin	NOUN
iajs-314	150	21	)	)	PUNCT
iajs-314	150	22	.	.	PUNCT
iajs-314	151	1	proc	proc	PROPN
iajs-314	151	2	natl	natl	PROPN
iajs-314	151	3	acad	acad	PROPN
iajs-314	151	4	sci	sci	PROPN
iajs-314	151	5	usa	usa	PROPN
iajs-314	151	6	74:739–43	74:739–43	PROPN
iajs-314	151	7	.	.	PUNCT
iajs-314	152	1	20thompson	20thompson	NUM
iajs-314	152	2	,	,	PUNCT
iajs-314	152	3	d.	d.	PROPN
iajs-314	152	4	;	;	PUNCT
iajs-314	152	5	pepys	pepys	PROPN
iajs-314	152	6	mb	mb	PROPN
iajs-314	152	7	.	.	PROPN
iajs-314	152	8	and	and	CCONJ
iajs-314	152	9	wood	wood	NOUN
iajs-314	152	10	sp	sp	NOUN
iajs-314	152	11	.	.	PUNCT
iajs-314	152	12	(	(	PUNCT
iajs-314	152	13	1999	1999	NUM
iajs-314	152	14	)	)	PUNCT
iajs-314	152	15	.	.	PUNCT
iajs-314	153	1	the	the	DET
iajs-314	153	2	physiological	physiological	ADJ
iajs-314	153	3	structure	structure	NOUN
iajs-314	153	4	of	of	ADP
iajs-314	153	5	human	human	ADJ
iajs-314	153	6	creactive	creactive	ADJ
iajs-314	153	7	protein	protein	NOUN
iajs-314	153	8	and	and	CCONJ
iajs-314	153	9	its	its	PRON
iajs-314	153	10	complex	complex	NOUN
iajs-314	153	11	with	with	ADP
iajs-314	153	12	phosphocholine	phosphocholine	NOUN
iajs-314	153	13	.	.	PUNCT
iajs-314	154	1	structure	structure	NOUN
iajs-314	154	2	7:169	7:169	NUM
iajs-314	154	3	–	–	PUNCT
iajs-314	154	4	77	77	NUM
iajs-314	154	5	.	.	PUNCT
iajs-314	155	1	21ridker	21ridker	NUM
iajs-314	155	2	,	,	PUNCT
iajs-314	155	3	pm	pm	NOUN
iajs-314	155	4	.	.	PUNCT
iajs-314	155	5	;	;	PUNCT
iajs-314	156	1	cushman	cushman	PROPN
iajs-314	156	2	m.	m.	NOUN
iajs-314	156	3	;	;	PUNCT
iajs-314	156	4	stampfer	stampfer	PROPN
iajs-314	156	5	mj	mj	PROPN
iajs-314	156	6	.	.	PROPN
iajs-314	156	7	;	;	PUNCT
iajs-314	156	8	tracy	tracy	PROPN
iajs-314	156	9	rp	rp	PROPN
iajs-314	156	10	.	.	PUNCT
iajs-314	156	11	and	and	CCONJ
iajs-314	156	12	hennekens	hennekens	PROPN
iajs-314	156	13	ch	ch	PROPN
iajs-314	156	14	.	.	PUNCT
iajs-314	156	15	(	(	PUNCT
iajs-314	156	16	1997	1997	NUM
iajs-314	156	17	)	)	PUNCT
iajs-314	156	18	.	.	PUNCT
iajs-314	157	1	inflammation	inflammation	NOUN
iajs-314	157	2	,	,	PUNCT
iajs-314	157	3	aspirin	aspirin	NOUN
iajs-314	157	4	,	,	PUNCT
iajs-314	157	5	and	and	CCONJ
iajs-314	157	6	the	the	DET
iajs-314	157	7	risk	risk	NOUN
iajs-314	157	8	of	of	ADP
iajs-314	157	9	cardiovascular	cardiovascular	ADJ
iajs-314	157	10	disease	disease	NOUN
iajs-314	157	11	in	in	ADP
iajs-314	157	12	apparently	apparently	ADV
iajs-314	157	13	healthy	healthy	ADJ
iajs-314	157	14	men	man	NOUN
iajs-314	157	15	[	[	X
iajs-314	157	16	published	publish	VERB
iajs-314	157	17	erratum	erratum	PROPN
iajs-314	157	18	appears	appear	VERB
iajs-314	157	19	in	in	ADP
iajs-314	157	20	n	n	CCONJ
iajs-314	157	21	engl	engl	PROPN
iajs-314	157	22	j	j	PROPN
iajs-314	157	23	med	med	PROPN
iajs-314	157	24	(	(	PUNCT
iajs-314	157	25	1997	1997	NUM
iajs-314	157	26	)	)	PUNCT
iajs-314	158	1	337:356	337:356	NOUN
iajs-314	158	2	]	]	X
iajs-314	158	3	.	.	PUNCT
iajs-314	159	1	n	n	PROPN
iajs-314	159	2	engl	engl	PROPN
iajs-314	159	3	j	j	PROPN
iajs-314	159	4	med	me	VERB
iajs-314	159	5	1997;336:973–9	1997;336:973–9	PROPN
iajs-314	159	6	.	.	PUNCT
iajs-314	160	1	22ridker	22ridker	NUM
iajs-314	160	2	,	,	PUNCT
iajs-314	160	3	pm	pm	NOUN
iajs-314	160	4	.	.	PUNCT
iajs-314	160	5	;	;	PUNCT
iajs-314	161	1	hennekens	hennekens	PROPN
iajs-314	161	2	ch	ch	PROPN
iajs-314	161	3	.	.	PROPN
iajs-314	161	4	;	;	PUNCT
iajs-314	161	5	buring	bur	VERB
iajs-314	161	6	je	je	PROPN
iajs-314	161	7	.	.	PUNCT
iajs-314	162	1	and	and	CCONJ
iajs-314	162	2	rifai	rifai	VERB
iajs-314	162	3	n.	n.	PROPN
iajs-314	162	4	(	(	PUNCT
iajs-314	162	5	2000	2000	NUM
iajs-314	162	6	)	)	PUNCT
iajs-314	162	7	.	.	PUNCT
iajs-314	163	1	c	c	X
iajs-314	163	2	-	-	PUNCT
iajs-314	163	3	reactive	reactive	ADJ
iajs-314	163	4	protein	protein	NOUN
iajs-314	163	5	and	and	CCONJ
iajs-314	163	6	other	other	ADJ
iajs-314	163	7	markers	marker	NOUN
iajs-314	163	8	of	of	ADP
iajs-314	163	9	inflammation	inflammation	NOUN
iajs-314	163	10	in	in	ADP
iajs-314	163	11	the	the	DET
iajs-314	163	12	prediction	prediction	NOUN
iajs-314	163	13	of	of	ADP
iajs-314	163	14	cardiovascular	cardiovascular	ADJ
iajs-314	163	15	disease	disease	NOUN
iajs-314	163	16	in	in	ADP
iajs-314	163	17	women	woman	NOUN
iajs-314	163	18	.	.	PUNCT
iajs-314	164	1	n	n	PROPN
iajs-314	164	2	engl	engl	PROPN
iajs-314	164	3	j	j	PROPN
iajs-314	164	4	med	med	PROPN
iajs-314	164	5	342:836–43	342:836–43	PROPN
iajs-314	164	6	.	.	PUNCT
iajs-314	165	1	23koenig	23koenig	NUM
iajs-314	165	2	,	,	PUNCT
iajs-314	165	3	w.	w.	PROPN
iajs-314	165	4	;	;	PUNCT
iajs-314	165	5	sund	sund	PROPN
iajs-314	165	6	m.	m.	PROPN
iajs-314	165	7	;	;	PUNCT
iajs-314	165	8	frohlich	frohlich	NOUN
iajs-314	165	9	m.	m.	NOUN
iajs-314	165	10	;	;	PUNCT
iajs-314	165	11	fischer	fischer	PROPN
iajs-314	165	12	hg	hg	PROPN
iajs-314	165	13	.	.	PROPN
iajs-314	165	14	;	;	PUNCT
iajs-314	165	15	lowel	lowel	PROPN
iajs-314	165	16	h.	h.	PROPN
iajs-314	165	17	;	;	PUNCT
iajs-314	165	18	doring	dore	VERB
iajs-314	165	19	a.	a.	NOUN
iajs-314	165	20	;	;	PUNCT
iajs-314	165	21	et	et	PROPN
iajs-314	165	22	al.(1999	al.(1999	PROPN
iajs-314	165	23	)	)	PUNCT
iajs-314	165	24	.	.	PUNCT
iajs-314	166	1	c	c	PROPN
iajs-314	166	2	reactive	reactive	ADJ
iajs-314	166	3	protein	protein	NOUN
iajs-314	166	4	,	,	PUNCT
iajs-314	166	5	a	a	DET
iajs-314	166	6	sensitive	sensitive	ADJ
iajs-314	166	7	marker	marker	NOUN
iajs-314	166	8	of	of	ADP
iajs-314	166	9	inflammation	inflammation	NOUN
iajs-314	166	10	,	,	PUNCT
iajs-314	166	11	predicts	predict	VERB
iajs-314	166	12	future	future	ADJ
iajs-314	166	13	risk	risk	NOUN
iajs-314	166	14	of	of	ADP
iajs-314	166	15	coronary	coronary	ADJ
iajs-314	166	16	heart	heart	NOUN
iajs-314	166	17	disease	disease	NOUN
iajs-314	166	18	in	in	ADP
iajs-314	166	19	initially	initially	ADV
iajs-314	166	20	healthy	healthy	ADJ
iajs-314	166	21	middle	middle	ADJ
iajs-314	166	22	-	-	PUNCT
iajs-314	166	23	aged	aged	ADJ
iajs-314	166	24	men	man	NOUN
iajs-314	166	25	:	:	PUNCT
iajs-314	166	26	results	result	NOUN
iajs-314	166	27	from	from	ADP
iajs-314	166	28	the	the	DET
iajs-314	166	29	monica	monica	NOUN
iajs-314	166	30	(	(	PUNCT
iajs-314	166	31	monitoring	monitor	VERB
iajs-314	166	32	trends	trend	NOUN
iajs-314	166	33	and	and	CCONJ
iajs-314	166	34	determinants	determinant	NOUN
iajs-314	166	35	in	in	ADP
iajs-314	166	36	cardiovascular	cardiovascular	ADJ
iajs-314	166	37	disease	disease	NOUN
iajs-314	166	38	)	)	PUNCT
iajs-314	166	39	augsburg	augsburg	PROPN
iajs-314	166	40	cohort	cohort	NOUN
iajs-314	166	41	study	study	NOUN
iajs-314	166	42	,	,	PUNCT
iajs-314	166	43	1984	1984	NUM
iajs-314	166	44	to	to	ADP
iajs-314	166	45	1992	1992	NUM
iajs-314	166	46	.	.	PUNCT
iajs-314	167	1	circulation	circulation	NOUN
iajs-314	167	2	99:237–42	99:237–42	NOUN
iajs-314	167	3	.	.	PUNCT
iajs-314	168	1	24rost	24rost	NUM
iajs-314	168	2	,	,	PUNCT
iajs-314	168	3	ns	ns	NUM
iajs-314	168	4	.	.	PUNCT
iajs-314	168	5	;	;	PUNCT
iajs-314	168	6	wolf	wolf	PROPN
iajs-314	168	7	pa	pa	PROPN
iajs-314	168	8	.	.	PROPN
iajs-314	168	9	;	;	PUNCT
iajs-314	169	1	kase	kase	PROPN
iajs-314	169	2	cs	cs	PROPN
iajs-314	169	3	.	.	PROPN
iajs-314	169	4	;	;	PUNCT
iajs-314	169	5	kelly	kelly	PROPN
iajs-314	169	6	-	-	PUNCT
iajs-314	169	7	hayes	hayes	PROPN
iajs-314	169	8	m.	m.	NOUN
iajs-314	169	9	;	;	PUNCT
iajs-314	169	10	silbershatz	silbershatz	PROPN
iajs-314	169	11	h.	h.	PROPN
iajs-314	169	12	;	;	PUNCT
iajs-314	169	13	massaro	massaro	PROPN
iajs-314	169	14	jm	jm	PROPN
iajs-314	169	15	.	.	PROPN
iajs-314	169	16	;	;	PUNCT
iajs-314	169	17	et	et	PROPN
iajs-314	169	18	al	al	PROPN
iajs-314	169	19	.	.	PROPN
iajs-314	170	1	(	(	PUNCT
iajs-314	170	2	2001	2001	NUM
iajs-314	170	3	)	)	PUNCT
iajs-314	170	4	.	.	PUNCT
iajs-314	171	1	plasma	plasma	NOUN
iajs-314	171	2	concentration	concentration	NOUN
iajs-314	171	3	of	of	ADP
iajs-314	171	4	c	c	NOUN
iajs-314	171	5	-	-	PUNCT
iajs-314	171	6	reactive	reactive	ADJ
iajs-314	171	7	protein	protein	NOUN
iajs-314	171	8	and	and	CCONJ
iajs-314	171	9	risk	risk	NOUN
iajs-314	171	10	of	of	ADP
iajs-314	171	11	ischemic	ischemic	ADJ
iajs-314	171	12	stroke	stroke	NOUN
iajs-314	171	13	and	and	CCONJ
iajs-314	171	14	transient	transient	VERB
iajs-314	171	15	ischemic	ischemic	ADJ
iajs-314	171	16	attack	attack	NOUN
iajs-314	171	17	:	:	PUNCT
iajs-314	171	18	the	the	DET
iajs-314	171	19	framingham	framingham	PROPN
iajs-314	171	20	study	study	PROPN
iajs-314	171	21	.	.	PUNCT
iajs-314	172	1	stroke	stroke	NOUN
iajs-314	172	2	32:2575–9	32:2575–9	NUM
iajs-314	172	3	.	.	PUNCT
iajs-314	173	1	25albert	25albert	NUM
iajs-314	173	2	,	,	PUNCT
iajs-314	173	3	cm	cm	PROPN
iajs-314	173	4	,	,	PUNCT
iajs-314	173	5	ma	ma	PROPN
iajs-314	173	6	j.	j.	PROPN
iajs-314	173	7	;	;	PUNCT
iajs-314	173	8	rifai	rifai	PROPN
iajs-314	173	9	n.	n.	PROPN
iajs-314	173	10	;	;	PUNCT
iajs-314	173	11	stampfer	stampfer	PROPN
iajs-314	173	12	mj	mj	PROPN
iajs-314	173	13	.	.	PROPN
iajs-314	173	14	and	and	CCONJ
iajs-314	173	15	ridker	ridker	PROPN
iajs-314	173	16	pm	pm	PROPN
iajs-314	173	17	.	.	PUNCT
iajs-314	174	1	(	(	PUNCT
iajs-314	174	2	2002	2002	NUM
iajs-314	174	3	)	)	PUNCT
iajs-314	174	4	.	.	PUNCT
iajs-314	175	1	prospective	prospective	ADJ
iajs-314	175	2	study	study	NOUN
iajs-314	175	3	of	of	ADP
iajs-314	175	4	c	c	PROPN
iajs-314	175	5	reactive	reactive	ADJ
iajs-314	175	6	protein	protein	NOUN
iajs-314	175	7	,	,	PUNCT
iajs-314	175	8	homocysteine	homocysteine	NOUN
iajs-314	175	9	,	,	PUNCT
iajs-314	175	10	and	and	CCONJ
iajs-314	175	11	plasma	plasma	NOUN
iajs-314	175	12	lipid	lipid	NOUN
iajs-314	175	13	levels	level	NOUN
iajs-314	175	14	as	as	ADP
iajs-314	175	15	predictors	predictor	NOUN
iajs-314	175	16	of	of	ADP
iajs-314	175	17	sudden	sudden	ADJ
iajs-314	175	18	cardiac	cardiac	ADJ
iajs-314	175	19	death	death	NOUN
iajs-314	175	20	.	.	PUNCT
iajs-314	176	1	circulation	circulation	NOUN
iajs-314	176	2	105:2595–9	105:2595–9	NUM
iajs-314	176	3	.	.	PUNCT
iajs-314	177	1	26ridker	26ridker	NUM
iajs-314	177	2	,	,	PUNCT
iajs-314	177	3	pm	pm	NOUN
iajs-314	177	4	.	.	PUNCT
iajs-314	177	5	;	;	PUNCT
iajs-314	177	6	stampfer	stampfer	PROPN
iajs-314	177	7	mj	mj	PROPN
iajs-314	177	8	.	.	PUNCT
iajs-314	178	1	and	and	CCONJ
iajs-314	178	2	rifai	rifai	VERB
iajs-314	178	3	n.	n.	PROPN
iajs-314	178	4	(	(	PUNCT
iajs-314	178	5	2001	2001	NUM
iajs-314	178	6	)	)	PUNCT
iajs-314	178	7	.	.	PUNCT
iajs-314	179	1	novel	novel	ADJ
iajs-314	179	2	risk	risk	NOUN
iajs-314	179	3	factors	factor	NOUN
iajs-314	179	4	for	for	ADP
iajs-314	179	5	systemic	systemic	ADJ
iajs-314	179	6	atherosclerosis	atherosclerosis	NOUN
iajs-314	179	7	:	:	PUNCT
iajs-314	179	8	a	a	DET
iajs-314	179	9	comparison	comparison	NOUN
iajs-314	179	10	of	of	ADP
iajs-314	179	11	c	c	NOUN
iajs-314	179	12	-	-	PUNCT
iajs-314	179	13	reactive	reactive	ADJ
iajs-314	179	14	protein	protein	NOUN
iajs-314	179	15	,	,	PUNCT
iajs-314	179	16	fibrinogen	fibrinogen	NOUN
iajs-314	179	17	,	,	PUNCT
iajs-314	179	18	homocysteine	homocysteine	NOUN
iajs-314	179	19	,	,	PUNCT
iajs-314	179	20	lipoprotein(a	lipoprotein(a	PROPN
iajs-314	179	21	)	)	PUNCT
iajs-314	179	22	,	,	PUNCT
iajs-314	179	23	and	and	CCONJ
iajs-314	179	24	standard	standard	ADJ
iajs-314	179	25	cholesterol	cholesterol	NOUN
iajs-314	179	26	screening	screening	NOUN
iajs-314	179	27	as	as	ADP
iajs-314	179	28	predictors	predictor	NOUN
iajs-314	179	29	of	of	ADP
iajs-314	179	30	peripheral	peripheral	ADJ
iajs-314	179	31	arterial	arterial	ADJ
iajs-314	179	32	disease	disease	NOUN
iajs-314	179	33	.	.	PUNCT
iajs-314	180	1	jama	jama	PROPN
iajs-314	180	2	285:2481–5	285:2481–5	NUM
iajs-314	180	3	.	.	PUNCT
iajs-314	181	1	27ridker	27ridker	NUM
iajs-314	181	2	,	,	PUNCT
iajs-314	181	3	pm	pm	NOUN
iajs-314	181	4	.	.	PUNCT
iajs-314	182	1	(	(	PUNCT
iajs-314	182	2	2003	2003	NUM
iajs-314	182	3	)	)	PUNCT
iajs-314	182	4	.	.	PUNCT
iajs-314	183	1	clinical	clinical	ADJ
iajs-314	183	2	application	application	NOUN
iajs-314	183	3	of	of	ADP
iajs-314	183	4	c	c	NOUN
iajs-314	183	5	-	-	PUNCT
iajs-314	183	6	reactive	reactive	ADJ
iajs-314	183	7	protein	protein	NOUN
iajs-314	183	8	for	for	ADP
iajs-314	183	9	cardiovascular	cardiovascular	ADJ
iajs-314	183	10	disease	disease	NOUN
iajs-314	183	11	detection	detection	NOUN
iajs-314	183	12	and	and	CCONJ
iajs-314	183	13	prevention	prevention	NOUN
iajs-314	183	14	.	.	PUNCT
iajs-314	184	1	circulation	circulation	NOUN
iajs-314	184	2	107	107	NUM
iajs-314	184	3	:	:	PUNCT
iajs-314	185	1	363–369	363–369	NUM
iajs-314	185	2	.	.	PUNCT
iajs-314	186	1	28libby	28libby	NUM
iajs-314	186	2	,	,	PUNCT
iajs-314	186	3	p.	p.	NOUN
iajs-314	186	4	;	;	PUNCT
iajs-314	186	5	ridker	ridker	NOUN
iajs-314	186	6	pm	pm	PROPN
iajs-314	186	7	.	.	PUNCT
iajs-314	187	1	and	and	CCONJ
iajs-314	187	2	maseri	maseri	ADJ
iajs-314	187	3	a.(2002	a.(2002	PROPN
iajs-314	187	4	)	)	PUNCT
iajs-314	187	5	.	.	PUNCT
iajs-314	188	1	inflammation	inflammation	NOUN
iajs-314	188	2	and	and	CCONJ
iajs-314	188	3	atherosclerosis	atherosclerosis	NOUN
iajs-314	188	4	.	.	PUNCT
iajs-314	189	1	circulation	circulation	NOUN
iajs-314	189	2	105:1135–1143	105:1135–1143	NOUN
iajs-314	189	3	.	.	PUNCT
iajs-314	190	1	29tziakas	29tziakas	NUM
iajs-314	190	2	,	,	PUNCT
iajs-314	190	3	dn	dn	PROPN
iajs-314	190	4	.	.	PROPN
iajs-314	190	5	;	;	PUNCT
iajs-314	190	6	chalikias	chalikias	PROPN
iajs-314	190	7	gk	gk	PROPN
iajs-314	190	8	.	.	PROPN
iajs-314	190	9	;	;	PUNCT
iajs-314	190	10	hatzinikolaou	hatzinikolaou	PROPN
iajs-314	190	11	hi	hi	INTJ
iajs-314	190	12	.	.	PUNCT
iajs-314	190	13	;	;	PUNCT
iajs-314	190	14	parissis	parissis	PROPN
iajs-314	190	15	jt	jt	PROPN
iajs-314	190	16	.	.	PROPN
iajs-314	190	17	;	;	PUNCT
iajs-314	190	18	papadopoulos	papadopoulos	PROPN
iajs-314	190	19	ed	ed	PROPN
iajs-314	190	20	.	.	PUNCT
iajs-314	190	21	;	;	PUNCT
iajs-314	190	22	et	et	PROPN
iajs-314	190	23	al.(2003	al.(2003	PROPN
iajs-314	190	24	)	)	PUNCT
iajs-314	190	25	.	.	PUNCT
iajs-314	191	1	anti	anti	ADJ
iajs-314	191	2	-	-	ADJ
iajs-314	191	3	inflammatory	inflammatory	ADJ
iajs-314	191	4	cytokine	cytokine	NOUN
iajs-314	191	5	profile	profile	NOUN
iajs-314	191	6	in	in	ADP
iajs-314	191	7	acute	acute	ADJ
iajs-314	191	8	coronary	coronary	ADJ
iajs-314	191	9	syndromes	syndrome	NOUN
iajs-314	191	10	:	:	PUNCT
iajs-314	191	11	behavior	behavior	NOUN
iajs-314	191	12	of	of	ADP
iajs-314	191	13	interleukin-10	interleukin-10	PROPN
iajs-314	191	14	in	in	ADP
iajs-314	191	15	association	association	NOUN
iajs-314	191	16	with	with	ADP
iajs-314	191	17	serum	serum	NOUN
iajs-314	191	18	metalloproteinases	metalloproteinase	NOUN
iajs-314	191	19	and	and	CCONJ
iajs-314	191	20	proinflammatory	proinflammatory	ADJ
iajs-314	191	21	cytokines	cytokine	NOUN
iajs-314	191	22	.	.	PUNCT
iajs-314	192	1	int	int	NOUN
iajs-314	192	2	j	j	PROPN
iajs-314	192	3	cardiol	cardiol	NOUN
iajs-314	192	4	92	92	NUM
iajs-314	192	5	:	:	PUNCT
iajs-314	192	6	169–175	169–175	NUM
iajs-314	192	7	.	.	PUNCT
iajs-314	193	1	30bogavac	30bogavac	NUM
iajs-314	193	2	-	-	PUNCT
iajs-314	193	3	stanojevic	stanojevic	ADJ
iajs-314	193	4	,	,	PUNCT
iajs-314	193	5	n.	n.	NOUN
iajs-314	193	6	;	;	PUNCT
iajs-314	193	7	djurovic	djurovic	PROPN
iajs-314	193	8	s.	s.	PROPN
iajs-314	193	9	;	;	PUNCT
iajs-314	193	10	jelic	jelic	PROPN
iajs-314	193	11	-	-	PUNCT
iajs-314	193	12	ivanovic	ivanovic	PROPN
iajs-314	193	13	z.	z.	PROPN
iajs-314	193	14	;	;	PUNCT
iajs-314	193	15	spasojevic	spasojevic	PROPN
iajs-314	193	16	-	-	PUNCT
iajs-314	193	17	kalimanovska	kalimanovska	PROPN
iajs-314	193	18	v.	v.	PROPN
iajs-314	193	19	and	and	CCONJ
iajs-314	193	20	kalimanovska	kalimanovska	PROPN
iajs-314	193	21	-	-	ADJ
iajs-314	193	22	ostric	ostric	ADJ
iajs-314	193	23	d.(2003	d.(2003	PROPN
iajs-314	193	24	)	)	PUNCT
iajs-314	193	25	.	.	PUNCT
iajs-314	194	1	circulating	circulate	VERB
iajs-314	194	2	transforming	transform	VERB
iajs-314	194	3	growth	growth	NOUN
iajs-314	194	4	factor	factor	NOUN
iajs-314	194	5	-	-	PUNCT
iajs-314	194	6	beta1	beta1	NOUN
iajs-314	194	7	,	,	PUNCT
iajs-314	194	8	lipoprotein(a	lipoprotein(a	PROPN
iajs-314	194	9	)	)	PUNCT
iajs-314	194	10	and	and	CCONJ
iajs-314	194	11	cellular	cellular	ADJ
iajs-314	194	12	adhesion	adhesion	NOUN
iajs-314	194	13	molecules	molecule	NOUN
iajs-314	194	14	in	in	ADP
iajs-314	194	15	angiographically	angiographically	ADV
iajs-314	194	16	assessed	assess	VERB
iajs-314	194	17	coronary	coronary	ADJ
iajs-314	194	18	artery	artery	NOUN
iajs-314	194	19	disease	disease	NOUN
iajs-314	194	20	.	.	PUNCT
iajs-314	195	1	clin	clin	PROPN
iajs-314	195	2	chem	chem	NOUN
iajs-314	195	3	lab	lab	NOUN
iajs-314	195	4	med	me	VERB
iajs-314	195	5	41	41	NUM
iajs-314	195	6	:	:	PUNCT
iajs-314	195	7	893–898	893–898	NUM
iajs-314	195	8	.	.	PUNCT
iajs-314	196	1	31kempe	31kempe	NUM
iajs-314	196	2	,	,	PUNCT
iajs-314	196	3	s.	s.	PROPN
iajs-314	196	4	;	;	PUNCT
iajs-314	196	5	heinz	heinz	PROPN
iajs-314	196	6	p	p	PROPN
iajs-314	196	7	,	,	PUNCT
iajs-314	196	8	kokai	kokai	PROPN
iajs-314	196	9	e.	e.	PROPN
iajs-314	196	10	;	;	PUNCT
iajs-314	196	11	devergne	devergne	PROPN
iajs-314	196	12	o.	o.	NOUN
iajs-314	196	13	;	;	PUNCT
iajs-314	196	14	marx	marx	PROPN
iajs-314	196	15	n.	n.	PROPN
iajs-314	196	16	;	;	PUNCT
iajs-314	196	17	et	et	PROPN
iajs-314	196	18	al	al	PROPN
iajs-314	196	19	.	.	PUNCT
iajs-314	196	20	(	(	PUNCT
iajs-314	196	21	2009	2009	NUM
iajs-314	196	22	)	)	PUNCT
iajs-314	196	23	.	.	PUNCT
iajs-314	197	1	epstein	epstein	PROPN
iajs-314	197	2	-	-	PUNCT
iajs-314	197	3	barr	barr	PROPN
iajs-314	197	4	virus	virus	PROPN
iajs-314	197	5	induced	induce	VERB
iajs-314	197	6	gene-3	gene-3	NUM
iajs-314	197	7	is	be	AUX
iajs-314	197	8	expressed	express	VERB
iajs-314	197	9	in	in	ADP
iajs-314	197	10	human	human	ADJ
iajs-314	197	11	atheroma	atheroma	NOUN
iajs-314	197	12	plaques	plaque	NOUN
iajs-314	197	13	.	.	PUNCT
iajs-314	198	1	am	be	AUX
iajs-314	198	2	j	j	PROPN
iajs-314	198	3	pathol	pathol	NOUN
iajs-314	198	4	175	175	NUM
iajs-314	198	5	:	:	PUNCT
iajs-314	198	6	440–447	440–447	NUM
iajs-314	198	7	.	.	PUNCT
iajs-314	199	1	32wang	32wang	NUM
iajs-314	199	2	,	,	PUNCT
iajs-314	199	3	b.	b.	PROPN
iajs-314	199	4	;	;	PUNCT
iajs-314	199	5	dai	dai	PROPN
iajs-314	199	6	s.	s.	PROPN
iajs-314	199	7	;	;	PUNCT
iajs-314	199	8	dong	dong	PROPN
iajs-314	199	9	z.	z.	PROPN
iajs-314	199	10	;	;	PUNCT
iajs-314	199	11	sun	sun	PROPN
iajs-314	199	12	y.	y.	PROPN
iajs-314	199	13	;	;	PUNCT
iajs-314	199	14	song	song	PROPN
iajs-314	199	15	x.	x.	PROPN
iajs-314	199	16	;	;	PUNCT
iajs-314	199	17	et	et	PROPN
iajs-314	199	18	al	al	PROPN
iajs-314	199	19	.	.	PUNCT
iajs-314	199	20	(	(	PUNCT
iajs-314	199	21	2014	2014	NUM
iajs-314	199	22	)	)	PUNCT
iajs-314	199	23	.	.	PUNCT
iajs-314	200	1	the	the	DET
iajs-314	200	2	modulation	modulation	NOUN
iajs-314	200	3	of	of	ADP
iajs-314	200	4	endoplasmicreticulum	endoplasmicreticulum	NOUN
iajs-314	200	5	stress	stress	NOUN
iajs-314	200	6	by	by	ADP
iajs-314	200	7	chemical	chemical	NOUN
iajs-314	200	8	chaperone	chaperone	NOUN
iajs-314	200	9	upregulates	upregulates	PROPN
iajs-314	200	10	immune	immune	ADJ
iajs-314	200	11	negative	negative	ADJ
iajs-314	200	12	cytokine	cytokine	NOUN
iajs-314	200	13	il-35	il-35	ADP
iajs-314	200	14	in	in	ADP
iajs-314	200	15	apolipoprotein	apolipoprotein	ADJ
iajs-314	200	16	e	e	NOUN
iajs-314	200	17	-	-	ADJ
iajs-314	200	18	deficient	deficient	ADJ
iajs-314	200	19	mice	mouse	NOUN
iajs-314	200	20	.	.	PUNCT
iajs-314	201	1	plos	plos	PROPN
iajs-314	201	2	one	one	NUM
iajs-314	201	3	9(1	9(1	NUM
iajs-314	201	4	):	):	PUNCT
iajs-314	201	5	e87787	e87787	PROPN
iajs-314	201	6	.	.	PUNCT
iajs-314	202	1	498	498	NUM
iajs-314	202	2	|	|	ADV
iajs-314	202	3	chemistry	chemistry	NOUN
iajs-314	202	4	2014	2014	NUM
iajs-314	202	5	)	)	PUNCT
iajs-314	203	1	عام	عام	ADP
iajs-314	203	2	3(العدد	3(العدد	NUM
iajs-314	203	3	27المجلد	27المجلد	NUM
iajs-314	204	1	مجلة	مجلة	VERB
iajs-314	204	2	إبن	إبن	NOUN
iajs-314	204	3	الھيثم	الھيثم	NOUN
iajs-314	204	4	للعلوم	للعلوم	NOUN
iajs-314	204	5	الصرفة	الصرفة	NOUN
iajs-314	205	1	و	و	PRON
iajs-314	205	2	التطبيقية	التطبيقية	ADJ
iajs-314	205	3	ibn	ibn	PROPN
iajs-314	205	4	al	al	PROPN
iajs-314	205	5	-	-	PUNCT
iajs-314	205	6	haitham	haitham	PROPN
iajs-314	205	7	jour	jour	X
iajs-314	205	8	.	.	PROPN
iajs-314	205	9	for	for	ADP
iajs-314	205	10	pure	pure	ADJ
iajs-314	205	11	&	&	CCONJ
iajs-314	205	12	appl	appl	PROPN
iajs-314	205	13	.	.	PUNCT
iajs-314	206	1	sci	sci	PROPN
iajs-314	206	2	.	.	PUNCT
iajs-314	206	3	vol	vol	NOUN
iajs-314	206	4	.	.	PROPN
iajs-314	207	1	27	27	NUM
iajs-314	207	2	(	(	PUNCT
iajs-314	207	3	3	3	NUM
iajs-314	207	4	)	)	PUNCT
iajs-314	207	5	2014	2014	NUM
iajs-314	207	6	33vahdat	33vahdat	NUM
iajs-314	207	7	,	,	PUNCT
iajs-314	207	8	k.	k.	PROPN
iajs-314	207	9	;	;	PUNCT
iajs-314	207	10	jafari	jafari	PROPN
iajs-314	207	11	sm	sm	PROPN
iajs-314	207	12	.	.	PROPN
iajs-314	207	13	;	;	PUNCT
iajs-314	207	14	pazoki	pazoki	PROPN
iajs-314	207	15	r.	r.	PROPN
iajs-314	207	16	and	and	CCONJ
iajs-314	207	17	nabipour	nabipour	PROPN
iajs-314	207	18	i.	i.	NOUN
iajs-314	207	19	(	(	PUNCT
iajs-314	207	20	2007	2007	NUM
iajs-314	207	21	)	)	PUNCT
iajs-314	207	22	.	.	PUNCT
iajs-314	208	1	concurrent	concurrent	PROPN
iajs-314	208	2	increased	increase	VERB
iajs-314	208	3	hs	hs	PROPN
iajs-314	208	4	-	-	PROPN
iajs-314	208	5	crp	crp	PROPN
iajs-314	208	6	and	and	CCONJ
iajs-314	208	7	chronic	chronic	ADJ
iajs-314	208	8	infection	infection	NOUN
iajs-314	208	9	are	be	AUX
iajs-314	208	10	associated	associate	VERB
iajs-314	208	11	with	with	ADP
iajs-314	208	12	cad	cad	PROPN
iajs-314	208	13	,	,	PUNCT
iajs-314	208	14	a	a	DET
iajs-314	208	15	large	large	ADJ
iajs-314	208	16	population	population	NOUN
iajs-314	208	17	study	study	NOUN
iajs-314	208	18	.	.	PUNCT
iajs-314	209	1	indian	indian	PROPN
iajs-314	209	2	journal	journal	PROPN
iajs-314	209	3	of	of	ADP
iajs-314	209	4	medical	medical	ADJ
iajs-314	209	5	sciences	science	NOUN
iajs-314	209	6	61	61	NUM
iajs-314	209	7	:	:	SYM
iajs-314	209	8	135	135	NUM
iajs-314	209	9	-	-	SYM
iajs-314	209	10	143	143	NUM
iajs-314	209	11	.	.	PUNCT
iajs-314	210	1	34pasupathi	34pasupathi	NUM
iajs-314	210	2	,	,	PUNCT
iajs-314	210	3	p.	p.	NOUN
iajs-314	210	4	;	;	PUNCT
iajs-314	211	1	rao	rao	PROPN
iajs-314	211	2	yy	yy	PROPN
iajs-314	211	3	.	.	PUNCT
iajs-314	211	4	;	;	PUNCT
iajs-314	211	5	farook	farook	PROPN
iajs-314	211	6	j.	j.	PROPN
iajs-314	211	7	;	;	PUNCT
iajs-314	211	8	saravanan	saravanan	PROPN
iajs-314	211	9	g.	g.	PROPN
iajs-314	211	10	and	and	CCONJ
iajs-314	211	11	bakthavathsalam	bakthavathsalam	PROPN
iajs-314	211	12	g.(2009	g.(2009	PROPN
iajs-314	211	13	)	)	PUNCT
iajs-314	211	14	.	.	PUNCT
iajs-314	212	1	oxidative	oxidative	ADJ
iajs-314	212	2	stress	stress	NOUN
iajs-314	212	3	and	and	CCONJ
iajs-314	212	4	cardiac	cardiac	ADJ
iajs-314	212	5	biomarkers	biomarker	NOUN
iajs-314	212	6	in	in	ADP
iajs-314	212	7	patients	patient	NOUN
iajs-314	212	8	with	with	ADP
iajs-314	212	9	acute	acute	ADJ
iajs-314	212	10	myocardial	myocardial	ADJ
iajs-314	212	11	infarction	infarction	NOUN
iajs-314	212	12	.	.	PUNCT
iajs-314	213	1	european	european	ADJ
iajs-314	213	2	journal	journal	PROPN
iajs-314	213	3	of	of	ADP
iajs-314	213	4	scientific	scientific	ADJ
iajs-314	213	5	research	research	NOUN
iajs-314	213	6	27	27	NUM
iajs-314	213	7	:	:	PUNCT
iajs-314	213	8	275	275	NUM
iajs-314	213	9	-	-	SYM
iajs-314	213	10	285	285	NUM
iajs-314	213	11	.	.	PUNCT
iajs-314	213	12	table	table	NOUN
iajs-314	213	13	no.(1	no.(1	NOUN
iajs-314	213	14	):	):	PUNCT
iajs-314	213	15	clinical	clinical	ADJ
iajs-314	213	16	characteristics	characteristic	NOUN
iajs-314	213	17	of	of	ADP
iajs-314	213	18	iraqi	iraqi	ADJ
iajs-314	213	19	patients	patient	NOUN
iajs-314	213	20	and	and	CCONJ
iajs-314	213	21	control	control	NOUN
iajs-314	213	22	groups	group	NOUN
iajs-314	213	23	characteristics	characteristic	NOUN
iajs-314	213	24	patients	patient	NOUN
iajs-314	213	25	n=47	n=47	PROPN
iajs-314	213	26	control	control	VERB
iajs-314	213	27	n=	n=	ADJ
iajs-314	213	28	32	32	NUM
iajs-314	213	29	p	p	NOUN
iajs-314	213	30	value	value	NOUN
iajs-314	213	31	age	age	NOUN
iajs-314	213	32	(	(	PUNCT
iajs-314	213	33	years	year	NOUN
iajs-314	213	34	)	)	PUNCT
iajs-314	214	1	50±	50±	PROPN
iajs-314	214	2	4.3	4.3	NUM
iajs-314	214	3	56±	56±	NUM
iajs-314	214	4	6.9	6.9	NUM
iajs-314	214	5	n.s	n.s	PROPN
iajs-314	214	6	sex	sex	NOUN
iajs-314	214	7	(	(	PUNCT
iajs-314	214	8	male/	male/	NUM
iajs-314	214	9	female	female	NOUN
iajs-314	214	10	)	)	PUNCT
iajs-314	214	11	21/26	21/26	NUM
iajs-314	214	12	13/19	13/19	NUM
iajs-314	215	1	n.s	n.s	PROPN
iajs-314	215	2	tc	tc	PROPN
iajs-314	215	3	(	(	PUNCT
iajs-314	215	4	mg/	mg/	PROPN
iajs-314	215	5	dl	dl	PROPN
iajs-314	215	6	)	)	PUNCT
iajs-314	215	7	228.61±	228.61±	NUM
iajs-314	215	8	21.05	21.05	NUM
iajs-314	215	9	175.34±	175.34±	NUM
iajs-314	215	10	12.05	12.05	NUM
iajs-314	215	11	p	p	NOUN
iajs-314	215	12	<	<	X
iajs-314	215	13	0.005	0.005	NUM
iajs-314	215	14	the	the	DET
iajs-314	215	15	data	datum	NOUN
iajs-314	215	16	are	be	AUX
iajs-314	215	17	given	give	VERB
iajs-314	215	18	as	as	ADP
iajs-314	215	19	the	the	DET
iajs-314	215	20	mean	mean	NOUN
iajs-314	215	21	±sd	±sd	PROPN
iajs-314	215	22	.	.	PUNCT
iajs-314	216	1	tc	tc	PRON
iajs-314	216	2	:	:	PUNCT
iajs-314	216	3	total	total	ADJ
iajs-314	216	4	cholesterol	cholesterol	NOUN
iajs-314	216	5	,	,	PUNCT
iajs-314	216	6	n.s	n.s	PROPN
iajs-314	216	7	:	:	PUNCT
iajs-314	216	8	nonsignificant	nonsignificant	ADJ
iajs-314	216	9	.	.	PUNCT
iajs-314	217	1	table	table	NOUN
iajs-314	217	2	no.(2	no.(2	NOUN
iajs-314	217	3	):	):	PUNCT
iajs-314	217	4	plasma	plasma	NOUN
iajs-314	217	5	il-35	il-35	ADP
iajs-314	217	6	levels	level	NOUN
iajs-314	217	7	and	and	CCONJ
iajs-314	217	8	hs	hs	PROPN
iajs-314	217	9	-	-	PROPN
iajs-314	217	10	crp	crp	NOUN
iajs-314	217	11	in	in	ADP
iajs-314	217	12	patients	patient	NOUN
iajs-314	217	13	and	and	CCONJ
iajs-314	217	14	control	control	PROPN
iajs-314	217	15	group	group	NOUN
iajs-314	217	16	characteristics	characteristic	NOUN
iajs-314	217	17	patients	patient	NOUN
iajs-314	217	18	control	control	VERB
iajs-314	217	19	p	p	NOUN
iajs-314	217	20	value	value	NOUN
iajs-314	217	21	il-35	il-35	ADP
iajs-314	217	22	(	(	PUNCT
iajs-314	217	23	pg	pg	PROPN
iajs-314	217	24	/	/	SYM
iajs-314	217	25	dl	dl	PROPN
iajs-314	217	26	)	)	PUNCT
iajs-314	217	27	36.21±	36.21±	NUM
iajs-314	217	28	3.52	3.52	NUM
iajs-314	217	29	22.21±	22.21±	NUM
iajs-314	217	30	2.01	2.01	NUM
iajs-314	217	31	p	p	NOUN
iajs-314	217	32	<	<	X
iajs-314	217	33	0.005	0.005	NUM
iajs-314	217	34	hs	hs	PROPN
iajs-314	217	35	-	-	PROPN
iajs-314	217	36	crp	crp	NOUN
iajs-314	217	37	(	(	PUNCT
iajs-314	217	38	mg	mg	PROPN
iajs-314	217	39	/	/	SYM
iajs-314	217	40	l	l	NOUN
iajs-314	217	41	)	)	PUNCT
iajs-314	217	42	4.36±	4.36±	NOUN
iajs-314	217	43	0.76	0.76	NUM
iajs-314	217	44	0.77±	0.77±	NOUN
iajs-314	218	1	0.25	0.25	NUM
iajs-314	218	2	p	p	NOUN
iajs-314	218	3	<	<	X
iajs-314	218	4	0.005	0.005	NUM
iajs-314	218	5	note	note	NOUN
iajs-314	218	6	:	:	PUNCT
iajs-314	218	7	the	the	DET
iajs-314	218	8	data	datum	NOUN
iajs-314	218	9	are	be	AUX
iajs-314	218	10	given	give	VERB
iajs-314	218	11	as	as	ADP
iajs-314	218	12	the	the	DET
iajs-314	218	13	mean	mean	NOUN
iajs-314	218	14	±sd	±sd	PROPN
iajs-314	218	15	499	499	NUM
iajs-314	218	16	|	|	ADV
iajs-314	218	17	chemistry	chemistry	NOUN
iajs-314	218	18	2014	2014	NUM
iajs-314	218	19	)	)	PUNCT
iajs-314	218	20	عام	عام	ADP
iajs-314	218	21	3(العدد	3(العدد	NUM
iajs-314	218	22	27المجلد	27المجلد	NUM
iajs-314	218	23	مجلة	مجلة	VERB
iajs-314	218	24	إبن	إبن	NOUN
iajs-314	218	25	الھيثم	الھيثم	NOUN
iajs-314	218	26	للعلوم	للعلوم	NOUN
iajs-314	218	27	الصرفة	الصرفة	NOUN
iajs-314	219	1	و	و	PRON
iajs-314	219	2	التطبيقية	التطبيقية	ADJ
iajs-314	219	3	ibn	ibn	PROPN
iajs-314	219	4	al	al	PROPN
iajs-314	219	5	-	-	PUNCT
iajs-314	219	6	haitham	haitham	PROPN
iajs-314	219	7	jour	jour	X
iajs-314	219	8	.	.	PROPN
iajs-314	219	9	for	for	ADP
iajs-314	219	10	pure	pure	ADJ
iajs-314	219	11	&	&	CCONJ
iajs-314	219	12	appl	appl	PROPN
iajs-314	219	13	.	.	PUNCT
iajs-314	220	1	sci	sci	PROPN
iajs-314	220	2	.	.	PUNCT
iajs-314	220	3	vol	vol	NOUN
iajs-314	220	4	.	.	PROPN
iajs-314	221	1	27	27	NUM
iajs-314	221	2	(	(	PUNCT
iajs-314	221	3	3	3	NUM
iajs-314	221	4	)	)	PUNCT
iajs-314	221	5	2014	2014	NUM
iajs-314	221	6	figure	figure	NOUN
iajs-314	221	7	no	no	INTJ
iajs-314	221	8	.	.	PUNCT
iajs-314	222	1	(	(	PUNCT
iajs-314	222	2	1	1	NUM
iajs-314	222	3	):	):	PUNCT
iajs-314	222	4	the	the	DET
iajs-314	222	5	correlation	correlation	NOUN
iajs-314	222	6	between	between	ADP
iajs-314	222	7	il-35	il-35	ADP
iajs-314	222	8	and	and	CCONJ
iajs-314	222	9	hs	hs	PROPN
iajs-314	222	10	-	-	PROPN
iajs-314	222	11	crp	crp	NOUN
iajs-314	222	12	in	in	ADP
iajs-314	222	13	patients	patient	NOUN
iajs-314	222	14	groups	group	NOUN
iajs-314	222	15	figure	figure	VERB
iajs-314	222	16	no	no	INTJ
iajs-314	222	17	.	.	PUNCT
iajs-314	223	1	(	(	PUNCT
iajs-314	223	2	2	2	NUM
iajs-314	223	3	):	):	PUNCT
iajs-314	223	4	the	the	DET
iajs-314	223	5	correlation	correlation	NOUN
iajs-314	223	6	between	between	ADP
iajs-314	223	7	il-35	il-35	PRON
iajs-314	223	8	and	and	CCONJ
iajs-314	223	9	tc	tc	X
iajs-314	223	10	in	in	ADP
iajs-314	223	11	patients	patient	NOUN
iajs-314	223	12	groups	group	NOUN
iajs-314	223	13	.	.	PUNCT
iajs-314	224	1	500	500	NUM
iajs-314	224	2	|	|	ADV
iajs-314	224	3	chemistry	chemistry	NOUN
iajs-314	224	4	2014	2014	NUM
iajs-314	224	5	)	)	PUNCT
iajs-314	224	6	عام	عام	ADP
iajs-314	224	7	3(العدد	3(العدد	NUM
iajs-314	224	8	27المجلد	27المجلد	NUM
iajs-314	224	9	مجلة	مجلة	VERB
iajs-314	224	10	إبن	إبن	NOUN
iajs-314	224	11	الھيثم	الھيثم	NOUN
iajs-314	224	12	للعلوم	للعلوم	NOUN
iajs-314	224	13	الصرفة	الصرفة	NOUN
iajs-314	225	1	و	و	PRON
iajs-314	225	2	التطبيقية	التطبيقية	ADJ
iajs-314	225	3	ibn	ibn	PROPN
iajs-314	225	4	al	al	PROPN
iajs-314	225	5	-	-	PUNCT
iajs-314	225	6	haitham	haitham	PROPN
iajs-314	225	7	jour	jour	X
iajs-314	225	8	.	.	PROPN
iajs-314	225	9	for	for	ADP
iajs-314	225	10	pure	pure	ADJ
iajs-314	225	11	&	&	CCONJ
iajs-314	225	12	appl	appl	PROPN
iajs-314	225	13	.	.	PUNCT
iajs-314	226	1	sci	sci	PROPN
iajs-314	226	2	.	.	PUNCT
iajs-314	226	3	vol	vol	NOUN
iajs-314	226	4	.	.	PROPN
iajs-314	227	1	27	27	NUM
iajs-314	227	2	(	(	PUNCT
iajs-314	227	3	3	3	NUM
iajs-314	227	4	)	)	PUNCT
iajs-314	227	5	2014	2014	NUM
iajs-314	227	6	وبروتين	وبروتين	NOUN
iajs-314	227	7	سي	سي	PRON
iajs-314	227	8	عالي	عالي	NOUN
iajs-314	227	9	الحساسية	الحساسية	PROPN
iajs-314	227	10	للمرضى	للمرضى	PROPN
iajs-314	227	11	العراقيين	العراقيين	PROPN
iajs-314	227	12	المصابين	المصابين	ADV
iajs-314	227	13	35	35	NUM
iajs-314	227	14	-	-	PUNCT
iajs-314	227	15	تقدير	تقدير	NOUN
iajs-314	227	16	انترلوكين	انترلوكين	PROPN
iajs-314	227	17	بأمراض	بأمراض	PROPN
iajs-314	227	18	األوعية	األوعية	PROPN
iajs-314	227	19	القلبية	القلبية	PROPN
iajs-314	227	20	وركــاء	وركــاء	PROPN
iajs-314	227	21	طعمة	طعمة	PROPN
iajs-314	227	22	سلوم	سلوم	VERB
iajs-314	227	23	السـعدي	السـعدي	PROPN
iajs-314	227	24	كلية	كلية	PROPN
iajs-314	227	25	التربية	التربية	NOUN
iajs-314	227	26	للعلوم	للعلوم	NOUN
iajs-314	227	27	الصرفة	الصرفة	NOUN
iajs-314	227	28	(	(	PUNCT
iajs-314	227	29	ابن	ابن	PROPN
iajs-314	227	30	الھيثم)/	الھيثم)/	PROPN
iajs-314	227	31	جامعة	جامعة	PROPN
iajs-314	227	32	بغداد	بغداد	PROPN
iajs-314	227	33	/قسم	/قسم	SYM
iajs-314	227	34	الكيمياء	الكيمياء	PROPN
iajs-314	227	35	2014تشرين	2014تشرين	PROPN
iajs-314	227	36	االول	االول	NOUN
iajs-314	227	37	28,قبل	28,قبل	PROPN
iajs-314	227	38	البحث	البحث	VERB
iajs-314	227	39	في	في	ADP
iajs-314	227	40	:	:	PUNCT
iajs-314	227	41	2014حزيران	2014حزيران	NUM
iajs-314	227	42	22استلم	22استلم	NUM
iajs-314	227	43	البحث	البحث	VERB
iajs-314	227	44	في	في	PROPN
iajs-314	227	45	:	:	PUNCT
iajs-314	227	46	الخالصة	الخالصة	PROPN
iajs-314	227	47	ضد	ضد	PROPN
iajs-314	227	48	األلتھابات	األلتھابات	PROPN
iajs-314	227	49	.	.	PUNCT
iajs-314	228	1	بروتين	بروتين	PROPN
iajs-314	228	2	سي	سي	DET
iajs-314	228	3	عالي	عالي	NOUN
iajs-314	228	4	الحساسية	الحساسية	NOUN
iajs-314	228	5	ھو	ھو	ADP
iajs-314	228	6	مؤشر	مؤشر	NOUN
iajs-314	228	7	12	12	NUM
iajs-314	228	8	-	-	PUNCT
iajs-314	228	9	عضو	عضو	NOUN
iajs-314	228	10	جديد	جديد	PROPN
iajs-314	228	11	من	من	PROPN
iajs-314	228	12	عائلة	عائلة	PROPN
iajs-314	228	13	انترلوكين	انترلوكين	PROPN
iajs-314	228	14	35انترلوكين	35انترلوكين	NUM
iajs-314	228	15	وبروتين	وبروتين	NOUN
iajs-314	228	16	سي	سي	PRON
iajs-314	228	17	عالي	عالي	NOUN
iajs-314	228	18	الحساسية	الحساسية	PROPN
iajs-314	228	19	عند	عند	PROPN
iajs-314	228	20	المرضى	المرضى	VERB
iajs-314	228	21	العراقيين	العراقيين	ADJ
iajs-314	228	22	35	35	NUM
iajs-314	228	23	-	-	PUNCT
iajs-314	228	24	أجريت	أجريت	NOUN
iajs-314	228	25	ھذه	ھذه	PROPN
iajs-314	228	26	الدراسة	الدراسة	PROPN
iajs-314	228	27	تقدير	تقدير	PROPN
iajs-314	228	28	تركيز	تركيز	PROPN
iajs-314	228	29	انترلوكين	انترلوكين	PROPN
iajs-314	228	30	لأللتھابات	لأللتھابات	PROPN
iajs-314	228	31	.	.	PUNCT
iajs-314	229	1	انثى	انثى	NOUN
iajs-314	229	2	)	)	PUNCT
iajs-314	230	1	26ذكراُ	26ذكراُ	PROPN
iajs-314	230	2	و	و	X
iajs-314	230	3	21حالة	21حالة	NUM
iajs-314	230	4	(	(	PUNCT
iajs-314	230	5	47حالة	47حالة	NUM
iajs-314	230	6	،	،	PROPN
iajs-314	230	7	قسمت	قسمت	PROPN
iajs-314	230	8	على	على	NOUN
iajs-314	230	9	مجموعتين	مجموعتين	NOUN
iajs-314	230	10	:	:	PUNCT
iajs-314	230	11	79المصابين	79المصابين	NUM
iajs-314	230	12	بامراض	بامراض	PROPN
iajs-314	230	13	األوعية	األوعية	PROPN
iajs-314	231	1	القلبية	القلبية	PROPN
iajs-314	231	2	.	.	PROPN
iajs-314	232	1	تضمنت	تضمنت	PROPN
iajs-314	232	2	الدراسة	الدراسة	PROPN
iajs-314	232	3	يطرة	يطرة	PROPN
iajs-314	232	4	.	.	PUNCT
iajs-314	233	1	حالة	حالة	PROPN
iajs-314	233	2	غير	غير	PROPN
iajs-314	233	3	مرضية	مرضية	PROPN
iajs-314	233	4	مجموعة	مجموعة	PROPN
iajs-314	233	5	الس	الس	PROPN
iajs-314	233	6	32يعانون	32يعانون	PROPN
iajs-314	234	1	من	من	NUM
iajs-314	234	2	امراض	امراض	PROPN
iajs-314	234	3	األوعية	األوعية	PROPN
iajs-314	234	4	القلبية	القلبية	PROPN
iajs-314	234	5	و	و	PROPN
iajs-314	234	6	35	35	NUM
iajs-314	234	7	-	-	PUNCT
iajs-314	234	8	وبروتين	وبروتين	NOUN
iajs-314	234	9	سي	سي	PRON
iajs-314	234	10	عالي	عالي	NOUN
iajs-314	234	11	الحساسية	الحساسية	NOUN
iajs-314	234	12	بطريقة	بطريقة	NOUN
iajs-314	234	13	اإلياليزا	اإلياليزا	ADJ
iajs-314	234	14	.	.	PUNCT
iajs-314	235	1	اظھرت	اظھرت	PROPN
iajs-314	235	2	النتائج	النتائج	PROPN
iajs-314	235	3	زيادة	زيادة	PROPN
iajs-314	235	4	في	في	DET
iajs-314	235	5	تركيز	تركيز	NOUN
iajs-314	235	6	انترلوكين	انترلوكين	PROPN
iajs-314	235	7	35قيس	35قيس	PROPN
iajs-314	235	8	تركيز	تركيز	NOUN
iajs-314	235	9	انترلوكين	انترلوكين	PROPN
iajs-314	235	10	وبروتين	وبروتين	PROPN
iajs-314	235	11	سي	سي	PRON
iajs-314	235	12	عالي	عالي	NOUN
iajs-314	235	13	الحساسية	الحساسية	PROPN
iajs-314	235	14	يُعبر	يُعبر	PROPN
iajs-314	235	15	عند	عند	PROPN
iajs-314	235	16	األشخاص	األشخاص	PROPN
iajs-314	235	17	35	35	NUM
iajs-314	235	18	-	-	PUNCT
iajs-314	235	19	وبروتين	وبروتين	NOUN
iajs-314	235	20	سي	سي	DET
iajs-314	235	21	عالي	عالي	NOUN
iajs-314	235	22	الحساسية	الحساسية	PROPN
iajs-314	235	23	في	في	PRON
iajs-314	235	24	مجموعة	مجموعة	PROPN
iajs-314	235	25	المرضى	المرضى	PROPN
iajs-314	235	26	.	.	PUNCT
iajs-314	236	1	انترلوكين	انترلوكين	PROPN
iajs-314	236	2	ن	ن	PROPN
iajs-314	236	3	ھذان	ھذان	ADJ
iajs-314	236	4	المؤشران	المؤشران	NOUN
iajs-314	236	5	الحياتيان	الحياتيان	VERB
iajs-314	236	6	مفيدين	مفيدين	VERB
iajs-314	236	7	في	في	ADP
iajs-314	236	8	تشخيص	تشخيص	PROPN
iajs-314	236	9	امراض	امراض	PROPN
iajs-314	236	10	األوعية	األوعية	PROPN
iajs-314	236	11	القلبية	القلبية	PROPN
iajs-314	236	12	.	.	PROPN
iajs-314	237	1	بشدة	بشدة	PROPN
iajs-314	237	2	في	في	PART
iajs-314	237	3	الحاالت	الحاالت	PROPN
iajs-314	237	4	المتقدمة	المتقدمة	PROPN
iajs-314	237	5	،	،	PROPN
iajs-314	237	6	لذا	لذا	PROPN
iajs-314	237	7	يمكن	يمكن	PROPN
iajs-314	238	1	أن	أن	PRON
iajs-314	238	2	يكو	يكو	INTJ
iajs-314	238	3	وبروتين	وبروتين	VERB
iajs-314	238	4	سي	سي	DET
iajs-314	238	5	عالي	عالي	NOUN
iajs-314	238	6	الحساسية	الحساسية	PROPN
iajs-314	238	7	في	في	DET
iajs-314	238	8	مجموعة	مجموعة	PROPN
iajs-314	238	9	المرضى	المرضى	PROPN
iajs-314	238	10	مقارنة	مقارنة	PROPN
iajs-314	238	11	بمجموعة	بمجموعة	NOUN
iajs-314	238	12	35حصلت	35حصلت	NUM
iajs-314	238	13	زيادة	زيادة	NOUN
iajs-314	238	14	معنوية	معنوية	NOUN
iajs-314	238	15	في	في	ADP
iajs-314	238	16	مستوى	مستوى	PROPN
iajs-314	238	17	انترلوكين	انترلوكين	PROPN
iajs-314	238	18	.	.	PUNCT
iajs-314	239	1	نتائج	نتائج	PROPN
iajs-314	239	2	وبروتين	وبروتين	PROPN
iajs-314	239	3	سي	سي	DET
iajs-314	239	4	عالي	عالي	NOUN
iajs-314	239	5	الحساسية	الحساسية	PROPN
iajs-314	239	6	لمجموعة	لمجموعة	PROPN
iajs-314	239	7	المرضى	المرضى	PROPN
iajs-314	240	1	35	35	NUM
iajs-314	240	2	-	-	PUNCT
iajs-314	240	3	وھناك	وھناك	PROPN
iajs-314	240	4	عالقة	عالقة	NOUN
iajs-314	240	5	موجبة	موجبة	PROPN
iajs-314	240	6	بين	بين	ADV
iajs-314	240	7	انترلوكين	انترلوكين	NOUN
iajs-314	240	8	(	(	PUNCT
iajs-314	240	9	p	p	X
iajs-314	240	10	<	<	X
iajs-314	240	11	0.005)السيطرة	0.005)السيطرة	PROPN
iajs-314	240	12	مؤشر	مؤشر	NOUN
iajs-314	240	13	محتمل	محتمل	PROPN
iajs-314	241	1	ضد	ضد	PROPN
iajs-314	241	2	األلتھابات	األلتھابات	PROPN
iajs-314	241	3	في	في	INTJ
iajs-314	241	4	امراض	امراض	PROPN
iajs-314	241	5	األوعية	األوعية	PROPN
iajs-314	241	6	القلبية	القلبية	PROPN
iajs-314	241	7	.	.	PROPN
iajs-314	242	1	35	35	NUM
iajs-314	242	2	-	-	PUNCT
iajs-314	242	3	الدراسة	الدراسة	NOUN
iajs-314	242	4	أظھرت	أظھرت	PROPN
iajs-314	242	5	انترلوكين	انترلوكين	PROPN
iajs-314	242	6	،	،	PROPN
iajs-314	242	7	بروتين	بروتين	PROPN
iajs-314	242	8	سي	سي	ADP
iajs-314	242	9	عالي	عالي	PROPN
iajs-314	242	10	الحساسية	الحساسية	PROPN
iajs-314	242	11	،	،	PROPN
iajs-314	242	12	امراض	امراض	PROPN
iajs-314	242	13	األوعية	األوعية	PROPN
iajs-314	242	14	القلبية.35داالت	القلبية.35داالت	PROPN
iajs-314	242	15	األلتھابات	األلتھابات	PROPN
iajs-314	242	16	،	،	PROPN
iajs-314	242	17	انترلوكين	انترلوكين	PROPN
iajs-314	242	18	الكلمات	الكلمات	VERB
iajs-314	242	19	المفتاحية	المفتاحية	PROPN
iajs-314	242	20	:	:	PUNCT